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Abstract 
Ghrelin, a peptide produced mainly by endocrine cells in the stomach, is an 
endogenous natural ligand for the ghrelin receptor which is alternatively known as 
the growth hormone secretagogue receptor. It is because ligand stimulation of the 
receptor in the pituitary stimulates growth hormone secretion. The presence of 
ghrelin in pancreatic endocrine islet cells has been reported previously. The peptide 
can increase the intracellular calcium ion concentration ([Ca"^]i) in p-cells thus 
affecting insulin secretion. However, the expression, regulation and function of the 
ghrelin system and its calcium signalling pathway in the exocrine pancreas remain 
undefined. 
In this study, the expression of ghrelin and ghrelin receptor was consistently 
found to be present in pancreatic acinar cells and its cell line AR42J using an array 
of techniques encompassing RT-PCR, Western blotting and immimocytochemistry. 
In addition, the effects of experimentally omeprazole-induced gastric acid inhibition, 
cerulein-induced acute pancreatitis and starvation on the expression of ghrelin and 
GHSR in the acinar cells were also investigated using semi-quantitative RT-PCR and 
Western blot approaches. The gene and protein expression of GHSR were 
significantly upregulated in gastric acid inhibition by about two-fold whereas 
downregulated in acute pancreatitis by about one-fourth, but no effects in starvation. 
Nevertheless, there were no differential effects of gastric acid inhibition, acute 
pancreatitis and starvation on the expression of ghrelin. 
As there are only limited and controversial observations of ghrelin action on 
pancreatic enzyme secretion, the in vitro studies of ghrelin in dispersed acinar cells 
and in pancreatic lobules were studied. Our data suggest that ghrelin displayed 
neither direct effect on dispersed acinar cells nor any additive or potentiative effects 
i 
with cholecystokinin-8 (CCK-8) and carbachol in rat isolated acinar cells. However, 
ghrelin showed an indirect dose-dependent inhibitory effect on pancreatic lobules. 
These data indicate that ghrelin might exhibit an indirect inhibitory effect on 
pancreatic exocrine secretion via the mediation of intrapancreatic innervation 
I 
Furthermore, the effects of ghrelin on [Ca ]i in AR42J cells by Fluo-4 
fluorescence imaging were also investigated. Results showed that CCK-8, ghrelin 
and growth hormone-releasing hexapeptide (GHRP-6) could stimulate the elevation 
of [Ca2+]i in AR42J cells in a dose-dependent manner. Ghrelin and GHRP-6 
produced a biphasic elevation in with an initial transient increase, followed 
by a sustained plateau. In the presence of (D-Lys^)-GHRP-6, a specific antagonist 
for the ghrelin receptor, the increase in [Ca ]i evoked by ghrelin was suppressed. 
The transient phase of the ghrelin response was inhibited while the plateau phase 
was completely abolished in the absence of extracellular Ca^^. When the cells were 
pretreated with 2-APB or xestospongin C, blockers of IPs-mediated Ca^^ release, the 
transient phase was abolished and the sustained phase was greatly inhibited. These 
results indicate that the initial transient phase of the [Ca ]i response could be due to 
IPs-dependent calcium mobilization of intracellular stores while the second 
sustained phase could be due to extracellular calcium influx across the plasma 
membrane. 
Taken together, all these data suggest the presence of a ghrelin system in the 
pancreatic acinar cells and its cell line AR42J, and it may have an action on the 
pancreatic exocrine cells in an autocrine and/or paracrine fashion. In addition, the 
regulated expression of GHSR by gastric acid inhibition and acute pancreatitis and 
their significance of changes may have a potential role in physiological and 
pathophysiological aspects of the pancreas. Moreover, ghrelin might exhibit an 
indirect inhibitory effect on pancreatic exocrine secretion via the mediation of 
ii 
intrapancreatic innervation. On the other hand, ghrelin stimulation of the ghrelin 
receptor could evoke a biphasic mobilization in AR42J cells, probably via the 
mediation of phospholipase C (PLC)/protein kinase C (PKC) pathway. In conclusion, 
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Chapter 1 Introduction 
1.1 The structure, function and regulation of growth hormone 
Growth hormone (GH), also known as somatotropin, is a protein hormone of 
about 190 amino acids with a molecular size around 22 kDa that is synthesized and 
secreted by cells called somatotrophs in the anterior pituitary. It has a helix-bundle 
structure with four antiparallel a-helices (Fig. 1-1) [De Vos et al 1992]. GH 
interacts with the GH receptor (GHR) to form a complex between the hormone and 
the extracellular domain of its GHR showing that the complex consists of one 
molecule of growth hormone per two molecules of receptor [Fuh et al 1992]. 
GH is a major participant in control of several complex physiologic processes, 
including growth and metabolism. Growth is a very complex process, and requires 
the coordination of several hormones. GH increases tissue formation by acting both 
directly and indirectly on target cells. The direct action of GH promotes the 
differentiation of precursor cells [Kopchick and Andry 2000]. GH also has important 
direct effects on protein, lipid and carbohydrate metabolism, which stimulates 
protein anabolism; enhances the utilization of fat by stimulating triglyceride 
breakdown and oxidation in adipocytes. It also maintains blood glucose within a 
normal range by suppressing the ability of insulin to stimulate uptake of glucose in 
peripheral tissues and enhance glucose synthesis in the liver [Kopchick and Andry 
2000]. Moreover, recent studies have suggested that GH may modulate emotion, 
behavior, or stress response by its direct actions on the rat brain [Yoshizato et al. 
1998]. 
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Figure 1-1. Ribbon diagram of the structure of growth hormone. The four 
antiparallel a-helices form a helix bundle. [MolViz 2004] 
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In addition, the indirect action of GH in stimulating body growth is to 
stimulate the liver and other tissues to secrete insulin-like growth factor-I (IGF-1) 
[Green et al 1985]. IGF-1 stimulates proliferation of chondrocytes (cartilage cells), 
resulting in bone growth while GH also has a direct effect on bone growth by 
stimulating differentiation of chondrocytes. Besides, IGF-1 appears to be the key 
controller in muscle growth by stimulating both differentiation and proliferation of 
myoblasts [Sacheck et al 2004]. It stimulates amino acid uptake and protein 
synthesis in muscle and other tissues. 
Production of GH is modulated by many factors, including stress, exercise, 
nutrition, sleep and GH itself. However, its classical primary controllers are two 
hypothalamic hormones (Fig. 1-2). Growth hormone-releasing hormone (GHRH) is 
a hypothalamic peptide that stimulates both synthesis and secretion of GH. 
Somatostatin is a peptide produced by several tissues in the body, including the 
hypothalamus. Somatostatin inhibits GH release in response to GHRH and to other 
stimulatory factors such as low blood glucose concentration. GH secretion is also 
part of a negative feedback loop involving IGF-1. High blood levels of IGF-1 lead to 
decrease in secretion of GH not only by directly suppressing the somatotrophs, but 
also by stimulating release of somatostatin from the hypothalamus. GH also feeds 
back to inhibit GHRH secretion, and probably has a direct autocrine inhibitory effect 
on secretion from the somatotrophs. 
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Figure 1-2. The classical regulated pathways of growth hormone synthesis and 
secretion from pituitary. Growth hormone-releasing hormone (GHRH); 
somatostatin (SS); insulin-like growth factor-I (IGF-1). 
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1.2 Historical perspective of growth hormone secretagogues 
Growth hormone secretagogues (GHS) are synthetic compounds of small 
molecular weight that possess potent stimulatory effect on GH secretion both in 
vitro and in vivo (Fig. 1-3). Originally in 1976, a small peptide, growth hormone 
-releasing peptide (GHRP)，derived from the pentapeptide met-enkephalin was 
synthesized before the isolation of GHRH in 1982 [Bowers et al. 1980; Momany et 
al. 1981]. This peptide is able to release GH at high dosage in vitro but not in vivo. 
Therefore, it serves as the prototype for designing new peptides. Later, the first 
peptidyl GHS, the hexapeptide GHRP-6 was developed, which was shown to be 
effective in stimulating GH secretion both in vitro and in vivo [Momany et al 1984; 
Bowers et al 1984]. Later research led to the development of other GHRPs such as 
GHRP-1, GHRP-2 [Bowers 1993]，hexarelin [Ghigo et al. 1994], and the modified 
pentapeptide ipamorelin [Raun et al 1998]. These peptides have been shown to 
produce potent GH responses in vitro and in vivo. However, they are poor substrates 
to peptidases and proteases thus should further increase their bioavailability. 
Based on the structure of GHRP-6, a large number of molecules that 
stimulating GH release were synthesized, including the non-peptidyl benzolactam 
L-692,429, the first nonpeptidyl GHS [Smith et al. 1993]. L-692,585 was developed, 
which is 20-fold more potent than L-692,429 (Fig. 1-3). The oral bioavailability of 
these peptides was improved. Apart from that, a new class of non-peptidyl GHS was 
developed, classified as spiropiperidine GHS. The first spiropiperidine GHS, called 
MK- 677, showed satisfactory performance in oral bioavailability and emerged as 
one of the most potent synthetic GHSs [Smith et al 1997; Patchett et al. 1995]. This 
GHS has undergone extensive clinical trials and was considered to be a potential 
therapeutic agent for disease like GH deficiency and critical illnesses [Casanueva 
and Dieguez 1999]. 
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Figure 1-3. Structures of growth hormone secretagogues. [National Library of Medicine 
2004] 
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1.3 Ghrelin and growth hormone secretagogue receptor 
1.3.1 Structure, tissue distribution and functions of ghrelin 
The endogenous peptide for the synthetic GHS was firstly identified and 
isolated from the rat stomach [Kojima et al 1999]. This hormone is called ghrelin, 
from ‘ghre,，a word root in Proto- Indo- European languages for 'grow'. Ghrelin is a 
28-amino acid peptide and the first natural peptide reported to have one of its amino 
acid residues (serine-3) modified post-translationally to be A2-octanoylated (Fig. 
1-4A) [Kojima et al 2001a]. Following the discovery of ghrelin—28, a second 
endogenous ghrelin form was isolated from a rat stomach extract. This peptide is a 
27-amino acid peptide with an «-octanoylated modification at its third serine residue, 
identical to ghrelin except for deletion of one glutamine (Fig. 1-4B). It is called 
des-G\n 14-ghrelin which is produced through an alternative splicing of rat ghrelin 
gene [Hosoda et al 2000a]. 
Since its discovery, ghrelin has been shown to be expressed in a variety of 
tissues. It is highly localized to the neuroendocrine X/A-like cells of the gastric 
mucosal layer of the stomach with concentrations decreasing distally along the 
intestine [Date et al 2000a; Hosoda et al. 2000b]. As expected, ghrelin expression is 
not restricted to the gastrointestinal tract. Ghrelin is also produced in the pituitary 
[Korbonits et al 2001], arcuate nucleus in hypothalamus, kidney [Mori et al. 2000], 
lung, liver, immune cells [Hattori et al. 2001], heart [Wang et al. 2002], placenta 
[Gualillo et al 2001], testis [Tena-Sempere et al. 2002]，ovary [Gaytan et al. 2003], 
and pancreatic islet cells [Date et al. 2002; Volante et al 2002a; Wierup et al 2004]. 
Ghrelin expression has also been found in ectopic adrenocorticotropic 
hormone-secreting tumors, gastrinomas, insulinomas [Korbonits et al. 2001] and in 










Figure 1-4. Schematic diagram of the rat ghrelin-28 structure (A) and rat 
(3fe>s-Glni4-ghrelin (B). The modification of «-octanoylated at third 
serine residue and molecular mass is about 3 kDa. Rat 
t/e^-Gln^"^-ghrelin has the same structure of ghrelin-28, except a 
deletion of glutamine at position 14. [Kojima et al. 2001b; Phoenix 
Pharmaceuticals. 2004] 
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Ghrelin stimulates GH release from pituitary cells in a dose-dependent manner 
in vitro. Intravenous injection of ghrelin induces potent GH release both in the rat 
and in humans [Kojima et al 1999; Tolle et al 2001]. In rodent, ghrelin also 
stimulates GH secretion when given in intracerebroventricular (ICV) injection [Date 
et al. 2000b; Tolle et al. 2001]. In addition to playing a role in GH release, ghrelin 
stimulates food intake, weight gain and reduces fat utilization in rodents [Tschop et 
al 2000]. In addition, ghrelin is a powerful stimulator of appetite. Human plasma 
ghrelin levels undergo relevant changes in relation to food intake, rising two-fold 
shortly before each meal and falling to basal level after eating [Cummings et al. 
2001]. Moreover, circulating level of ghrelin is decreased in obesity [Tschop et al. 
2001a], while they are increased in such conditions as malnutrition, cachexia, and 
anorexia nervosa [Otto et al 2001]. It is evident that ghrelin is an important 
regulator of food intake and energy homeostasis. Furthermore, ghrelin has been 
suggested that it stimulates gastric acid secretion, gastric motility as well as gastric 
emptying [Masuda et al 2000; Date et al 2001] Furthermore, exogenous ghrelin 
reduces cardiac afterload and increases cardiac output without affecting heart rate 
[Nagaya et al. 2001]. 
1.3.2 Structure and tissue distribution of GHSR 
The regulation of GH release from pituitary appears to be mediated by the 
interplay of two classical hypothalamic stimulatory and inhibitory regulator of GH 
release, GHRH and somatostain, respectively [Casanueva 1992]. In addition to this 
regulatory mechanism, GH release is also elicited by GHS and endogenous ghrelin. 
The action of GHS and ghrelin is mediated through a specific seven-transmembrane 
G-protein-coupled receptor called GHS receptor la (GHSR-la), which was 
identified using a non-peptidyl GHS，MK-677 as a ligand in the pituitary and 
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hypothalamus of humans in 1996 [Pong et al. 1996; Casanueva and Dieguez 1999; 
Dieguez and Casanueva 2000]. 
Two types of cDNAs for GHSR have been identified and designated as la and 
lb [Smith et al. 1997; Smith et al. 1999]. The GHSR type la consists of 366 amino 
acids with seven transmembrane regions whose molecular mass is approximately 41 
kDa (Fig. 1-5). On the other hand, type lb type consists of 289 amino acids with 
only five transmembrane regions. GHSR-la was demonstrated to confer high 
affinity，specific binding of ghrelin and lead to intracellular calcium mobilization 
([Ca2+]i) through stimulation of the G protein subunit in GHSR-la. In contrast, 
GHSR-lb fails to bind ghrelin. This binding affinity appears to be correlated with 
the GH stimulatory effect [Smith et al 1999; Petersenn et al 2001]. Thus the 
physiological significance of GHSR-lb remains undefined. 
GHSR-la is confined to somatotrophs of pituitary and to a very limited region 
in the hypothalamic arcuate nucleus, which is known to control the appetite [Yokote 
et al 1998; Shintani et al 2001]. At much lower levels GHSR-la is expressed in the 
thyroid gland, pancreas, spleen, myocardium, adrenal gland [Papotti et al 2000; 
Gnanapavan et al 2002], stomach, small intestine, colon [Date et al. 2000a]，liver 
[Murata et al 2002] and T-cells [Hattori et al. 2001]. Recently, the expression of 
GHSR-la has been demonstrated in rat testis [Tena-Sempere et al 2002; Barreiro et 
al. 2002], ovary [Gaytan et al 2003] and prostate cancer cells [Jeffery et al 2002]. 
In these tissues, co-expression of the GHSR-la and ghrelin appears to provide 
evidence of autocrine and/or paracrine-mediated pathways. The widespread of 
GHSR-la and ghrelin raises the possibility of multifunctional significance of ghrelin 






Figure 1-5. Schematic diagram of the human GHSR-la structure. The potential 
cysteine residues in forming disulfide bridges are linked. [Phoenix 
Pharmaceuticals. 2004] 
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1.4 Calcium signalling of growth hormone secretagogues 
The GHS-stimulated GH secretion is believed to be mediated through [Ca^^Ji 
changes. This increase in [Ca2+]i depends on different second messenger systems. 
Both peptidyl and non-peptidyl synthetic GHS caused an elevation of in 
somatotrophs [Bresson-Bepoldin and Dufy-Barbe 1994; Gracia-Navarro et al 2002; 
Herrington and Hille 1994; Glavaski-Joksimovic et al 2002]. Studies indicated that 
GHRP-6 elevated [Ca2+]i in rat somatotrophs in two distinct phases 
[Bresson-Bepoldin and Dufy-Barbe 1994;. Herrington and Hille 1994]. GHRP-6 
first produced a rapid transient elevation in [Ca2+]i，which may result from the 
release of Ca^^ from internal stores. The transient phase was followed by a sustained 
elevation in that persists for several minutes, even after removal of the 
agonist. The persistent elevation resulted from Ca^^ entry, probably through L-type 
voltage-dependent calcium channels on membrane. Thus, internal Ca^^ release and 
external Ca^^ entry contribute to GHRP-6-induced Ca^ "" elevations in rat 
somatotrophs. 
Because the first phase increment is extracellular Ca^^ independent, it is 
reasonable to believe that a second messenger system is involved in GHSR 
activation. There is evidence that phospholipase C (PLC) is one of the major 
components (Fig. 1-6). GHRP-6 increased the formation of 
inositol-1,4,5-triphosphate (IP3) in a dose-dependent manner in rat somatotrophs 
[Mau et al. 1995]. Furthermore, the stimulatory effect of L692,585 and GHRP-6 on 
[Ca2+]i elevation was blocked by the PLC inhibitor, U73122 [Glavaski-Joksimovic et 
al 2002; Bresson-Bepoldin and Dufy-Barbe 1994]. These results indicate that 
GHS-stimulated GH-secretion involves in PLC pathway with a resulting rise in 
cytosolic Ca2+. 
12 
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Figure 1-6. The proposed signalling pathways for GHS. The binding of GHSs to 
GHSR activates the PLC and adenylate cyclase (AC) pathways via 
G-proteins, leading to an increase in InsPs and the activity of PKC and 
PKA. InsPs the release Ca^^ from the endoplasmic reticulum (ER) and 
protein kinases phosphorylate ion channels to increase Ca^ "^  influx. This 
would lead to an increase in [Ca^^i and GH secretion. GTP-binding 
proteins (G proteins); phosphatidylinositol (a,)-bisphosphate (PIP2). 
[Wu^/ al 1996] 
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It is well known that GHRH activates the adenosine 3',5'-monophosphate 
(cAMP)/protein kinase A (PKA) pathway in somatotropes [Frohman et al. 1992; 
Harwood et al. 1984]. On the other hand, adenylate cyclase (AC) and PKA are also 
involved in GHS-induced secondary message system (Fig. 1-6). GHRP-2 increased 
the production of cAMP in ovine somatotropes [Wu et al. 1996]. Moreover, the 
stimulatory effect of L692,585 on elevation of was blocked by the AC 
inhibitor, SQ-22536 [Glavaski-Joksimovic et al. 2002]. 
On the other hand, the intracellular signalling pathways of ghrelin have been 
extensively investigated in a number of cells. In this regard, activation of 
mobilization by ghrelin was elucidated in pituitary somatotropes 
[Glavaski-Joksimovic et al 2003], arcuate nucleus neurons [Kohno et al 2003], 
pancreatic P-cells [Date et al 2002] and HEK-293 cells expressing the ghrelin 
receptor [Carreira et al. 2004]. In porcine pituitary somatotropes, perfusion with 1 
jiM ghrelin for 2 minutes produced a prompt transient increase in followed 
by a sustained decline to a plateau above the basal level [Malagon et al 2003; 
Glavaski-Joksimovic et al. 2003]. The plateau response was present even 30 minutes 
after the application of ghrelin. In transfected HEK-293 cells with highly expressing 
the ghrelin receptor, binding of ghrelin to the receptor also induced a biphasic 
increase of characterized by a transient rise, followed by a gradual decrease 
to a sustained plateau [Camina et al. 2003a; Camina et al 2003b; Carreira et al 
2004]. Ghrelin induces a biphasic cytosolic elevation characterized by a 
spike phase of the response. This reflects the Ca^^ mobilization of intracellular stores, 
followed by a sustained phase of the response. This later phase is, in turn, due to 
Ca2+ influx across the plasma membrane via the capacitative calcium channels. 
A number of potential second messengers involved in the action of ghrelin 
have been previously reported. In transfected HEK-293 cells, binding of ghrelin to 
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its receptor led to the mobilization of Ca2+ from intracellular IPs-sensitive stores, 
thus activating Ca^^ influx through L-type voltage sensitive calcium channels. This 
suggests that the spike phase reflects IPs-mediated intracellular mobilization of Ca^ "^  
while the plateau phase reflects the influx of extracellular Ca^^ across the plasma 
membrane [Camina et al. 2003a; Camina et al 2003b; Glavaski-Joksimovic et al 
2003; Howard et al 1996]. In contrast, some reports have shown that the response 
of porcine somatotrophs to ghrelin relies on the activation of three distinct systems 
of second messengers, including the AC/PKA, PLC/PKC, and extracellular Ca^ "" 
systems (Fig. 1-6) [Kohno et al 2003; Malagon et al 2003]. In arcuate nucleus 
neuron, ghrelin-induced increase depends mainly on the Ca^ "^  influx through 
N-type calcium channels and the AC/PKA pathway, but not the L-type calcium 
channels nor the PLC/PLC pathway [Kohno et al 2003]. 
1.5 Pancreas and functions of exocrine pancreas 
The pancreas is a flat and elongated organ, pinkish in color, which lies in close 
proximity to the duodenum (Fig. 1-7) [Gray 2000; Austgen et al. 2003]. It is covered 
with a very thin connective tissue capsule, partitioning the gland into lobules. The 
pancreas is of both an exocrine and an endocrine organ. The exocrine pancreas has 
two main functional elements: the acini, comprising about 84 %, and the ductal and 
centroacinar cells (also called principal cells), comprising about 5 % of total cell 
mass. On the other hand, the endocrine pancreas, i.e. the islet of Langerhans 
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Figure 1-7. Overview structure of pancreas. [Gray 2000] 
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Islet of Langerhans 
Figure 1-8. Histology examination of rat pancreatic tissue. Magnification: 20 X 
[Austgen et al 2003] 
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Pancreatic exocrine cells are arranged in grape-like clusters with 
membrane-bound secretory granules called acini (Fig. 1-9). The acinar cells from 
apically oriented complex with zymogen granules containing digestive enzymes that 
are exocytosed into the lumen of the acinus [Konturek et al. 2003a]. From there, 
these secretions flow into larger intralobular ducts, which eventually coalesce into 
the main pancreatic duct draining directly into the duodenum. Centroacinar cells are 
located at the junctions between intercalated ducts and acinar cells, and believed to 
serve as signal transducers for regulating the degranulation of acinar cells. Epithelial 
cells in pancreatic ducts are the source of the bicarbonate and water secreted by the 
pancreas [Austgen et al 2003]. In pancreatic duct cells, the bicarbonate is secreted 
into the lumen of the duct and hence into pancreatic juice. 
Embedded within this exocrine tissue are small clusters of cells called the 
Islets of Langerhans, which are the endocrine cells of the pancreas [Austgen et al 
2003]. Pancreatic islets have three major cell types, each of which produces a 
different endocrine product: a-cells (A-cells) secrete the hormone glucagon; p-cells 
(B-cells) produce insulin, which are the most numerous type of secretory cell within 
the islets; y-cells (D-cells) secrete the hormone somatostatin, which is also produced 
by a number of other endocrine cells in the body; PP cells, F cells secrete pancreatic 
polypeptides. Interestingly, different cell types within an islet are not randomly 
organized, p-cells are centrally located within the islets, notably in the core of islets 
while a-cells and y-cells are more abundant in the periphery. Islets are richly 
vascularized, allowing their secreted hormones ready access to the circulation. 
Although islets comprise only 1 % of the mass of the pancreas, they receive about 
10 to 15 % of the pancreatic blood flow. Additionally, they are innervated by 
parasympathetic and sympathetic neurons, and cholinergic and adrenergic nerves 
clearly modulate the secretion of insulin and glucagon, 
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Figure 1-9. Histology examination of rat pancreatic acinar cells arrange in 
grape-like clusters. Magnification: 40 X. [Austgen et al. 2003] 
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Pancreatic juice is composed of two secretory products critical to proper 
digestion: digestive enzymes and bicarbonate [Singer 1993; Austgen et al 2003]. 
The enzymes are synthesized and secreted from the exocrine acinar cells, whereas 
bicarbonate is secreted from the epithelial cells lining small pancreatic ducts. The 
pancreas secretes enzymes that collectively have the capacity to reduce all digestible 
macromolecules into smaller and absorbable forms. Four major groups of enzymes 
are critical to efficient digestion of our daily foodstuff, namely proteases, lipase, 
a-amylase, ribonuclease as well as deoxyribonuclease. 
Digestion of proteins is initiated by pepsin in the stomach, but the bulk of 
protein digestion is due to the actions of various pancreatic proteases. Several 
proteases are synthesized in the pancreas and secreted into the lumen of the small 
intestine. The major pancreatic proteases are trypsin, chymotrypsin, elastase and 
carboxypeptidase, which are synthesized and packaged into secretory vesicles as the 
inactive proenzymes called trypsinogen, chymotrypsinogen, proelastase and 
procarboxypeptidase, respectively. These proteases can digest protein into peptides 
and amino acids. In addition, membrane-bound peptidases located in small intestine 
are able to digest large peptides into amino acids. 
The major form of dietary fat is triglyceride, or neutral lipid. A triglyceride 
molecule cannot be directly absorbed across the intestinal mucosa. Rather, it must 
first be digested into 2-monoglycerides and two free fatty acids. The enzyme 
responsible for this hydrolytic action is pancreatic lipase, which is delivered into the 
lumen of the gut as a constituent of pancreatic juice. Sufficient quantities of bile 
salts from the liver must also be present in the lumen of the small intestine in order 
for lipase to efficiently digest dietary triglyceride into its absorbable forms. In view 
of this, normal digestion and absorption of dietary fat are critically dependent on 
adequate secretions from both the pancreas and liver. 
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The major dietary carbohydrate for many species is starch, a storage form of 
glucose in plants, a-amylase is the enzyme that hydrolyses starch to maltose, 
trisaccharide maltotriose and a-dextrins, a form of oligosaccharides of glucose. The 
major source of a-amylase in all species is pancreatic secretions, although some 
animals, including humans, also secrete salivary amylase. 
Sufficiency of pancreatic exocrine secretion is essential for efficient digestion 
of our daily foodstuff, thus normal absorption and assimilation take place. 
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1.6 Regulation of exocrine pancreatic function 
1.6.1 Neural and hormonal regulation 
Exocrine secretions of the pancreas are finely regulated in response to food 
stimuli emptied from the stomach into the small intestine. When food has emptied 
into the gastrointestinal system, a low level of exocrine secretion still occurs, which 
is considered as the basal secretion [Solomon 1994]. The basal pancreatic secretion 
could be mediated through a very low circulating level of cholecystokinin (CCK) 
and secretin, as well as the metabolically dependent secretion of enzymes from the 
acinar cells. 
The food-induced pancreatic exocrine secretion is modulated by both neural 
and hormonal pathways. Numerous neurotransmitters and neuropeptides released by 
the gut and pancreas contribute to the neural regulation control of the pancreatic 
exocrine secretion. Different receptors have been found on the plasma membrane of 
the pancreatic acinar cells. Muscarinic acetylcholine (ACh) receptor is one of the 
most important in regulating pancreatic secretion. A number of studies showed that 
ACh released from the intrapancreatic postganglionic cholinergic neurons acts 
directly on acinar and ductal cells in order to regulate the exocrine secretions 
[Solomon 1994; Chey and Chang 2001]. 
On the other hand, numerous enterohormones, especially CCK, secretin and 
gastrin, released by duodeno-jejunal mucosa, are responsible for controlling the 
pancreatic secretions. In response to the small peptides and fatty acids in the small 
intestine, synthesis of CCK by the endocrine I cells of duodenum is highly 
stimulated and CCK is released into the bloodstream [Rosewicz et al 1989]. As 
CCK binds to its receptors on pancreatic acini, large quantity of digestive enzymes 
is secreted from the pancreas to the lumen of duodenum. Similar to CCK, gastrin, 
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released by stomach in response to food stimuli also induces the secretion of 
digestive enzymes from the pancreas. In response to gastric acid in the duodenum, 
the release of secretin is rapidly increased in order to stimulate the secretion of 
pancreatic ductal bicarbonate. These enterohormones were originally believed to act 
via an endocrine pathway only. However, CCK and other enterohormones have 
recently been found to stimulate the pancreas by excitation of sensory nerves, thus 
triggering long vagvagal and short entero-pancreatic reflexes (Fig. 1-10) [Zabeilski 
et al 1995; Owyang 1996; Konturek et al. 2003b]. It is proposed that physiological 
plasma CCK levels act via stimulation of the vagal afferent pathway, whereas 
supraphysiological CCK levels act to stimulate intrapancreatic innervation and, to a 
lesser degree, direct on pancreatic acini (Fig. 1-10) [Li and Owyang 1993]. The 
pancreatic secretion is mainly mediated by long vago-vagal and short 
entero-pancreatic reflexes activated by stimulation of the CCK-receptors at sensory 
nerve terminals in the digestive system. The efferent vagal nerves to the pancreas 
release not only ACh but also other peptides such as gastrin-releasing peptide (GRP) 
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Figure 1-10. Schematic presentation of pancreatic enzyme secretion in response to 
CCK administered that is mediated via neurocrine route acting 
through long vago-vagal and short entero-pancreatic reflexes. 
Exogenous CCK in supraphysiological dose may stimulate pancreatic 
secretion by direct action on acinar cell receptors or via the 
intrapancreatic neurons. Cholecystokinin (CCK), acetylcholine 
(ACh), gastrin-releasing peptide (GRP) and vasoactive intestinal 
peptides (VIP). [Konturek et al. 2003b] 
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Apart from the classical neural and hormonal controls, a number of hormones, 
neuropeptides and neurotransmitters are involved in the stimulation of pancreatic 
secretion, such as, GRP, insulin, VIP, pituitary adenylate cyclase-activating peptide, 
histamine, substance P and tachykinins [Konturek et al 2003; Solomon 1994]. On 
the other hand, somatostatin is the major factor for inhibiting the exocrine secretion 
of pancreas. Other inhibitory regulators, such as, pancreatic polypeptide, leptin, 
peptide YY， neuropeptide Y, calcitonin gene-related peptide, glucagon, 
thyrotropin-releasing hormone, enkephalin, nitric oxide and dopamine, have also 
been involved in inhibition of pancreatic exocrine secretion [Konturek et al 2003a; 
Solomon 1994]. 
The pancreatic acinar cells have at least two distinct signalling transduction 
pathways for stimulating the insertion of zymogen granules, thus releasing digestive 
enzymes [Solomon 1994]. ACh and CCK both activate Gctq, which stimulates PLC, 
thus ultimately leading to the activation of PKC and releasing of Ca2+. On the other 
hand, secretin and VIP activate Gets’ which stimulates AC, leading to the production 
of cAMP and the activation of PKA [Konturek et al. 2003a; Konturek et al 
2003b]. 
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1.6.2 Omeprazole-induced gastric acid inhibition 
Omeprazole is a member of a new class of antisecretory compounds termed the 
substituted benzimidazoles (Fig. 1-11) that is acted by irreversible binding to the 
pump called H+/K+-ATPase at the secretory surface of gastric parietal cells [Sachs 
and Wallmark 1989]. Drugs that can inhibit this enzyme are often referred to as 
proton pump inhibitors. Omeprazole decreases the amount of acid output in the 
stomach. In view of this, omeprazole is used to treat certain conditions in which 
there is hypersecretion of gastric acid [Davidson 2004; Jackson et al. 2004]. For 
example, it is used to treat gastric and duodenal ulcers, and gastroesophageal reflux 
disease, a condition in which gastric acid reflexes into the esophagus [Asaka et al. 
1992]. Clinically, omeprazole is used in combination with antibiotics to treat ulcers 
that are closely associated with the infection by the bacteria called, Helicobacter 
pylori [Labenz et a/. 1993]. Omeprazole is also used to treat Zollinger-Ellison 
syndrome (gastrinoma), a condition in which the stomach produces extremely high 
levels of acid because of the hyperstimulation of the hormone gastrin abnormally 
secreted by the pancreatic endocrine tumor. 
Omeprazole-induced achlorhydria is associated with hypergastrinemia 
[Sundler et al 1986]. The secretion of gastrin is greatly stimulated by food in the 
stomach in combination with high antral pH. The long-term suppression of gastric 
acid secretion causes a sustained hypergastrinemia, which produced trophic effect on 
the gastric mucosa, particularly leading to proliferation of the enterochromaffm-like 
(ECL) cells as well as the levels of histidine decarboxylase and histamine gene 
expression [Larsson et al 1986; Eissele et al. 1991; Sundler et al. 1986]. However, 
the weight of the pancreas and the intestines, and the thickness of the mucosa of the 
antrum as well as small and large intestine were normally unaffected [Hakanson et 
al 1986; Hakanson et al. 1988]. Furthermore, omeprazole-induced hypergastrinemia 
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Figure 1-11. The structure of substituted benzimidazole, omeprazole. [National 
Library of Medicine 2004] 
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has been reported to increase the weight of the parathyroid gland and the parathyroid 
hormone gene expression in both rats and chicken [Gagnemo-Persson et al. 1994; 
Grimelius et al 1977]. Previous studies have shown that intraperitoneal 
administration of omeprazole caused an elevation of some pancreatic lysosomal 
enzymes, such as acid phosphatase, beta-galactosidase, lipase, 
N-acetyl-glucosaminidase, sulphatase, which may be responsible for the initiation of 
inflammation [Burdan et al 2000]. Thus, it is believed that omeprazole-induced 
achlorhydria alters the physiology of pancreas. It prompts us to investigate the 
omeprazole-induced regulation on ghrelin system in exocrine pancreas. 
1.6.3 Acute pancreatitis 
Acute pancreatitis is an inflammatory disease characterized by tissue edema, 
acinar necrosis, hemorrhage and fat necrosis as well as inflammation and 
perivascular infiltration in the pancreas [Schmidt et al 1992]. The major causes of 
acute pancreatitis are gallstones, alcohol use, viral infection, traumatic injury, and 
certain medications, such as estrogens, corticosteroids, and azathioprine. The 
mechanism that causes pancreatitis is not well known. It is thought that trypsinogen 
normally secreted by the pancreas in an inactive form becomes activated through the 
proteolytic cleavage of the N-terminal peptide trypsinogen-activating peptide to 
trypsin inside the pancreas. This in turn results in autodigestion of the pancreatic 
tissues [Neoptolemos et al. 2000; Steer 1998]. The CCK-secretagogue agonist, 
cerulein (Fig. 1-12) is commonly used for the induction of experimental acute 
pancreatitis. Cerulein is similar in action and composition to CCK. It stimulates 
gastric, biliary, and pancreatic secretion and certain smooth muscle, which is used as 
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Figure 1-12. The structure of CCK-secretagogue agonist, cemlein. [National Library of 
Medicine 2004] 
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As the pancreas is damaged, amylase and lipase would escape from the tissue 
and leak into the bloodstream, and thus plasma hyperamylasemia and 
hyperlipasemia are two primary biochemical indicators for the diagnosis of acute 
pancreatitis [Clavien et al. 1989]. In addition, plasma level of pancreatitis-associated 
protein (PAP) has also been utilized clinically to diagnose and monitor the evolution 
of acute pancreatitis. On the other hand, it is demonstrated that acute pancreatitis 
could regulate various gene components in pancreas. For instance, the mRNA for 
secretory protein PAP is almost absent in normal pancreas but is found to be 
over-expressed in the acute pancreatitis [Su et al. 1999; Friess et al. 1992]. Apart 
from that, cemlein-induced acute pancreatitis could upregulate the local 
renin-angiotensin system components, notably angiotensin II receptors, ATi and AT2 
in the pancreas [Leung et al 2000; Tsang et al 2003]. In addition, the 
cerulein-induced pancreatitis was associated with an upregulation of mRNA and 
protein for leptin in the pancreas [Konturek et al. 2001]. It is evident that both leptin 
and ghrelin have been described as important regulators of energy homeostasis and 
food intake, which appear to have opposing effects. Nevertheless, the regulation of 
ghrelin and its receptor in acute pancreatitis in pancreas is largely unknown to date. 
Thus, the potential regulation of ghrelin system by acute pancreatitis would be under 
investigation in this study. 
1.6.4 Starvation 
Starvation is the most severe form of malnutrition. It may result from fasting, 
famine, anorexia nervosa, catastrophic disease of the gastrointestinal tract, stroke or 
coma [Merck 2004]. The adaptation of the organism to starvation is characterized by 
metabolic and endocrine changes. The basic metabolic response to starvation is 
conservation of energy and body tissues [Van De Graaff and Fox 2000]. During 
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starvation, free fatty acids, ketone bodies and glycogen become the predominant 
fuels. [Schwartz and Seeley 1997]. As consequences, the body will mobilize its own 
tissues as a source of energy, which results in the destruction of organs and muscle. 
Apart from metabolic changes, starvation leading to the endocrine changes includes 
suppression of reproductive and thyroid function and stimulation of the 
hypothalamus-pituitary-adrenal axis [Schwartz and Seeley 1997], which may 
therefore facilitate the mobilization of fuel in peripheral tissues and CNS responses 
that promote the restoration of depleted adipose stores. In addition, most body 
systems are affected by starvation [Merck 2004]. Starvation suppresses immunity, 
particularly T-lymphocyte responses, and decreases resistance to infection [Chandra 
1980]. 
On the other hand, it is evident that some systems are regulated under 
starvation. The circulating leptin, which plays a crucial role in the homeostasis of 
body weight by regulating food intake and energy expenditure, falls rapidly with the 
onset of starvation [Faggioni et al 2000; Schwartz and Seeley 1997]. The leptin 
mRNA levels also decrease in fasting conditions in the rat gastric mucosa and in 
adipose tissue [Pico et al 2002]. Some studies have demonstrated that plasma 
ghrelin was markedly elevated in patients with malnutrition [Otto et al. 2001; 
Cummings et al 2002]. In addition, it is already clear that the mRNA level of gastric 
ghrelin was markedly upregulated by food deprivation [Gualillo et al 2002] and 
downregulated by food intake [Cummings et al 2001; Tschop et al 2001b] in rats. 
Moreover, stomach ghrelin mRNA levels and plasma ghrelin levels were increased 
in 72-hour fasted rats and decreased with re-feeding [Lee et al. 2002]. Thus, it is 
believed that the regulation of ghrelin system by starvation is physiologically 
significant in our gastrointestinal system. In this study, we attempted to determine 
the influence of ghrelin and ghrelin receptor in the rat pancreas under starvation. 
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1.7 Functions of ghrelin in pancreas 
In the exocrine pancreas, recent studies have been demonstrated the existence 
of ghrelin and ghrelin receptor mRNA in pancreas; ghrelin were co-localized 
exclusively with glucagon in rat islets, suggesting that ghrelin is produced in a-cells 
[Date et al 2002]. However, it is contradictory in the action of ghrelin on the 
endocrine pancreas. In anesthetized rats, perfusion of ghrelin to isolated pancreas 
directly inhibited the insulin responses to glucose [Egido et al. 2002; Lee et al. 
2002]. Some reports have shown that ghrelin sitmulated insulin in isolated rat 
pancreatic islets and increased the cytosolic free [Ca^^] in p-cells [Date et al 2002] 
as well as the perfusion of pancreas in both normal and diabetic anesthetized rats 
[Adeghate and Ponery 2002]. A recent report suggested that isolated pancreatic islets 
responded to a low ghrelin concentration (1-100 pmol/1) with a suppressed insulin 
secretion; high concentrations of ghrelin (>100 nmol/1) stimulated insulin secretion 
while its physiological range did not have any effect. Apart from that, intravenous 
administration of ghrelin was found to suppress basal as well as glucose-stimulated 
insulin secretion without affecting glucagon secretion [Salehi et al. 2004]. 
In addition to ghrelin effects on insulin secretion, ghrelin also increased 
glucagon secretion in isolated pancreatic islets in normal [Salehi et al. 2004] and 
diabetic rats [Adeghate and Parvez 2002] but without affecting glucagon secretion in 
vivo [Salehi et al. 2004]. Besides, the pancreatic somatostatin release was inhibited 
by perfusion of ghrelin in anesthetized rats [Egido et al. 2002]. 
On the other hand, limited information on the function of ghrelin in the 
exocrine pancreas was available. For example, a recent study demonstrated that 
pancreatic exocrine secretion was inhibited by ghrelin in anesthetized rats and in 
pancreatic lobules [Zhang et al 2001]. In an other study, centrally administered 
ghrelin stimulates pancreatic exocrine secretion through the vagal efferent nerve in 
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conscious rats [Sato et al 2003]. The potential role of ghrelin on exocrine secretion 
is still controversal. 
Apart from the endocrine and exocrine functions of ghrelin, administration of 
ghrelin could attenuate pancreatic damage in cerulein-induced pancreatitis 
[Dembinski et al 2003] and protective effect of ghrelin administration seemed to be 
related to the inhibition in inflammation process. Moreover, ghrelin was expressed 
in a quite prominent endocrine cell population in fetal pancreas, but remained less in 
adult islets, suggesting that ghrelin is developmentally regulated in islets [Wierup et 
al. 2002]. Moreover, ghrelin also promoted pancreatic adenocarcinoma cellular 
proliferation and invasiveness [Duxbury et al. 2003]. 
Notwithstanding these data available, there has so far been a lack of evidence 
for the existence and potential roles of the ghrelin system in the exocrine pancreas. 
Accordingly, the present study aimed at studying the expression, localization, 
regulation and function of ghrelin system in the exocrine pancreas, and its possible 
intracellular calcium signalling pathway during ligand stimulation. 
1.8 Aims of study 
The hypothesis of the study is that ghrelin system is present in pancreatic 
exocrine cells, which should also be subjected to some physiological and 
pathophysiological regulations. The functional role of ghrelin in pancreatic acinar 
secretion and the Ca^^ signalling pathway of ghrelin in AR42J cells are also tested. 
Accordingly, the present study aims specifically at: 
1. The evidence for the existence of ghrelin and ghrelin receptor in both 
isolated acinar cells and pancreatic exocrine AR42J cell line; 
2. The effects of gastric acid inhibition, acute pancreatitis and starvation on 
the expression of ghrelin and ghrelin receptor in isolated acinar cells; 
3. Evaluation of the effects of ghrelin on pancreatic enzyme secretion in 
isolated acinar cells and pancreatic lobules; 
4. Investigation of the intracellular calcium signalling pathway in response to 
the stimulation of ghrelin in AR42J cell line. 
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Chapter 2 Materials and methods 
2.1 Experimental animal and cell line models 
2.1.1 Rat model 
Male Sprague-Dawley (SD) rats aged 28 days weighing in the range of 75 to 
100 grams were used in all experiments, unless where otherwise indicated. The 
animals were bred and raised under a pathogen-free conditions, with a controlled 
ambient temperature of 22 土 1° C, relative humidity of 60 to 80 % and a 12-hour 
light/dark cycle, in the Laboratory Animal Services Center of the Chinese University 
of Hong Kong. Standard laboratory diet and tap water were applied ad libitum. 
Ethical approval of experimental procedures has been obtained from the Animal 
Experimentation Ethics Committee of the Chinese University of Hong Kong, Hong 
Kong. 
2.1.2 Isolation of pancreatic lobules and acinar cells 
Pancreatic lobules, containing intrapancreatic nerve terminals and islets in 
addition to exocrine cells, were prepared [Scheel and Palade 1975]. Pancreata were 
removed and rinsed with phosphate-buffered saline (PBS; 0.14M NaCl，2.7 mM KCl, 
8 mM anhydrous Na2HP04, 1.47 mM KH2PO4, pH 7.4). After trimming away 
peripancreatic fat and lymph nodes, the pancreatic tissue was divided into 4 mm x 5 
mm lobular units. 
The dissociation of functionally intact acini from pancreatic tissue using 
collagenase and hyaluronidase digestions with mild shearing forces has been well 
established and adequately modified [Amsterdam and Jamieson 1972; William et al 
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1977, Tsang et al. 2004a]. Pancreas was removed, rinsed with PBS, and trimmed 
from peripancreatic fat and lymph nodes. The pancreatic parenchyma was inflated 
with 5 ml dissociation medium using a 27 G needle in order to distend the tissue. The 
dissociation medium consisted of Kerbs-Henselit Bicarbonate (KHB)—Minimal 
Eagles Medium (MEM) (1:1) (Sigma-Aldrich, MO, USA), 60 U/ml purified 
collagenase (Sigma-Aldrich, MO, USA), 1.8 mg/ml hyaluronidase (ICN Biomedicals, 
OH, USA), 0.05 U/ml a-chymotrysin (Sigma-Aldrich, MO, USA), 0.2 mg/ml 
soybean trypsin inhibitor (Sigma-Aldrich, MO, USA) and 100 U/ml penicillin and 
100 ^g/ml streptomycin (Invitrogen, CA, USA). The inflated tissue was minced into 
small fragments and transferred into a vial containing 5 ml freshly prepared 
dissociation medium. The vial was then placed in a 37° C water bath with vigorous 
shaking for 15 minutes. Tissue was gently pipetted and filtered through a 150-|im 
nylon mesh screen (Sigma-Aldrich, MO, USA). Thereafter, the cell suspension was 
rinsed with 10 ml KHB-MEM buffer (1:1) containing 1 % (w/v) fraction V bovine 
serum albumin (BSA) (ICN Biomedicals, OH, USA) and centrifiiged at 1000 rpm at 
4 � C for 3 minutes. The acinar pellet was rinsed three more times, each with 10 ml 
KHB containing 4 % (w/v) BSA. 
2.1.3 Omeprazole-induced gastric acid inhibition 
The induction of gastric acid inhibition by omeprazole has been demonstrated 
[Burdan et al 2001]. The human therapeutic dose was 0.571 mg/kg of body weight 
[Arky 1999]. Due to the faster rat's metabolism, the dose for rat was increased 
10-times and fixed at 5.71 mg/kg of body weight. The SD rats were randomly 
assigned to omeprazole-induced group and control group. Omeprazole (Losec, Astra, 
Sweden) an inhibitor of H+/K+-ATPase (the proton pump) in secretory surface of 
gastric parietal cells, was administrated intraperitoneally twice a day for three days 
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at 12-hour time interval to rats in omeprazole-induced group (5.71 mg/kg of body 
weight) in order to inhibit significantly the gastric acid secretion in stomach. Rats in 
the control group received 0.9 % saline solution instead of omeprazole with the 
same volume and at the same time interval. Animals were sacrificed in the fourth 
day of the experiment. 
2.1.4 Cerulein-induced acute pancreatitis 
Intraperitoneal injection of CCK-secretagogue, cerulein (Pharmacia GmbH, 
Germany), is the most widely used method for the induction of an experimental acute 
pancreatitis by means of hyperstimulating the pancreatic digestive enzyme secretion 
[Lampel and Kem 1977; Tsang et al 2003b]. Prior to the experiments, SD rats were 
starved overnight but allowed with free access to water. Animals were randomly 
assigned to acute pancreatitis group and control group. In the acute pancreatitis group, 
a supramaximal dose of cerulein at 50 |ag/kg/h was intraperitoneally injected to 
animal at minute 0 and minute 60 in order to construct a mild edematous pancreatitis. 
In the control group, animals received 0.9 % saline solution instead of cerulein with 
the same volume and at the same time interval. Animals were sacrificed 60 minutes 
after the second injection. 
2.1.5 Starvation rat model 
SD rats were randomly assigned to starved group and control group. In the 
starved group, rats were treated in full 72-hour starvation but allowed with free 
access to tap water [Bertile et al. 2003; Hanus et al 2003; Ahima et al. 1999]. The 
fiill 72-hour starvation allows sufficient time for the stabilization of physiological 
changes in animals. In the control group, rats received standard laboratory diet and 
tap water. Animals were sacrificed in the fourth day of the experiment. 
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2.1.6 AR42J cell line 
The rat pancreatic exocrine tumor AR42J cell line (ATCC, VA, USA) was 
cultured in Kaighn's modification of Ham's F12 medium (F12K) (Invitrogen, CA, 
USA) with 10 % fetal bovine serum (Invitrogen, CA, USA) and antibiotics (100 
U/ml penicillin and 100 jig/ml streptomycin) (Invitrogen, CA, USA). The AR42J 
cells grow slowly in cluster, which do not form confluent monolayer. The medium 
was renewed every five days. The cell line was subcultured when patches of cells 
started to form dome-shape appearance. In sub-cultivation, the cluster of cells was 
dissociated into single cells by syringe with 18 G needle. 
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2.2 Reverse transcriptase-polymerase chain reaction 
2.2.1 Total RNA extraction and quantification 
Total RNA was individually extracted from pancreas, acinar cells, pituitary 
and stomach of SD rats, and AR42J cells using Trizol reagent (Invitrogen, CA, USA) 
[Leung et al 2000a]. Tissues were homogenized in Trizol reagent (0.1 g tissue/ 1 ml 
Trizol reagent) while cells was under vigorous vortex in 2 ml Trizol reagent. 
Samples were then incubated at room temperature for 5 minutes to allow complete 
dissociation of nucleoprotein complexes. Chloroform (0.2 ml chloroform/ 1 ml 
Trizol) was added to each sample and vigorously shaken for 15 seconds. All samples 
were then incubated for three additional minutes, followed by a centrifugation at 
12,000 g for 15 minutes at 4° C. The upper aqueous phase was carefully collected. 
RNA was precipitated by addition of isopropyl alcohol (0.5 ml isopropanol/ 1ml 
Trizol). After that, all samples were centrifuged at 12,000 g for 10 minutes at 4° C. 
The white pellets were collected and washed with 1.5 ml of cold 75 % ethanol, 
which were further centrifuged at 7,500 g for 5 minutes. Finally, pellets were dried 
by Speed Vac (Gene Co, NY, USA) for 3 minutes and dissolved in 0.1 ml diethyl 
pyrocarbonate (DEPC) (Acros, Belgium) treated water. 
Total RNA was quantified by spectrophotometer (Version 1.3, KCjunior, 
Bio-tek Instrument Inc., VT, USA). Total RNA concentration was calculated from 
the value of absorbance at wavelength 260 run (O.D. 260) x 40 x dilution factor and 
the purity of RNA obtained was determined by the ratio of O.D. 280 to O.D. 260. 
The calculated value lined between 1.6 and 2.0 was considered as pure. 
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2.2.2 Reverse transcription 
The first strand cDNA was synthesized using the Superscript First-Strand 
Synthesis System for RT-PCR (Invitrogen, CA, USA) [Lam and Leung 2003]. 5 昭 
of RNA in a total volume of 17.5 |il in DEPC-treated water was heated to 70° C for 
5 minutes to melt the secondary structure within the template. The RNA was cooled 
immediately on ice and added the mixture, containing 1 jig oligo-dTig primers, 1 X 
first strand buffer, 10 mM 1,4-dithiothreitol (DDT), 0.33 mM deoxynucleotide 
triphosphate (dNTP) mix, 20 units Rnase Out and 50 units SuperScript II RT and 
added the DEPC-treated water to final volume of 30 |il. The mixture was further 
incubated at 42° C for 1 hour. 
2.2.3 Polymerase chain reaction 
The first strand cDNA was subjected to PGR reaction. Various sets of 
oligonucleotide primers were synthesized (Invitrogen, CA, USA). Brief details of 
the genes, ghrelin [Date et al 2000a], GHSR, GADPH [Fort et al 1985] and P-actin 
[Nudel et al 1983] employed for the present study including the sequences of 
primers and expected PGR products are shown in Table 2-1. 
PGR was carried out in a total of 20 |il-reaction volume containing PGR buffer, 
1.5 mM MgCb, 0.2 mM dNTP mix, 0.5 |iM corresponding sense and anti-sense 
primers, template DNA and Taq DNA polymerase (Invitrogen, CA, USA). The 
reaction was initiated at 94° C for denaturing, then annealing at different 
temperature for different gene of interests, and finally extending at 72° C. The PGR 
cycles were repeated for 28-35 cycles. 
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Table 2-1 Rat oligonucleotide primers and expected product size used for the 
RT-PCR in the present study. 
Target Forward primer Reverse Primer PGR products 
gene (bp) 
Ghrelin CAG AGG ACA GAG GAC GCT GGA TGT GAG TTC 234 
AAG CAG AAG A TTG CTT AGG A 
GHSR GAG ATC GCT CAG ATC TAA TCC CCA AAC TGA 313 
AGC CAG TAG GGT TCT GC 
GADPH TCC CTC AAG ATT GTC AGA TCC ACA ACG GAT 309 
AGCAA ACATT 
p-actin AGT GTG ACG TTC ACA GAC TGA TCG TAC TCC 240 
TCC GT TGC TT 
2.2.4 Gel electrophoresis 
The PGR products were analyzed on a 1.5 % agarose gel (0.01 M 
ethylenediamine-tetraacetic (EDTA), agarose w/v in IX Tris-Acetate-EDTA (TAE) 
buffer, 0.04 M Tris-acetate) pre-stained with 40 \i\ of 1 mg/ml ethidium bromide 
(Invitrogen, CA, USA). The resulting bands were visualized using a camera 
equipped with an UV illuminator (FluroChem 8000 Advanced Fluorescence, 
Chemiluminescence and Visible Light Imaging, Alpha Innotech Corporation, CA, 
USA). 
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2.2.5 Optimization of semi-quantitative RT-PCR 
The optimization of semi-quantitative RT-PCR was previously described in 
detail [Lam and Leung 2003; Leung et al 2000b; Chan et al. 2000] Briefly, for the 
interpretation of semi-quantitative RT-PCR data, PGR reaction should be terminated 
when the products from genes of interest are detectable and are amplified within a 
linear range. The linear range of amplification occurs in the PGR cycles when 
reaction components are still in excess and the PGR products are accumulating at a 
constant rate. Experiments were conducted on each gene of interest for validation of 
PCR amplification in the logarithmic phase. cDNA mixtures were subjected to PGR 
amplification in a 25 |il reaction system for 21-36 cycles. The PCR products were 
electrophoresed on a 1.5 % agarose gel with ethidium bromide and the relative 
intensity of the PCR products were analyzed by a camera equipped with an UV 
illuminator (FluroChem 8000 Advanced Fluorescence, Chemiluminescence and 
Visible Light Imaging, Alpha Innotech Corporation, CA, USA). 
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2.3 Western blot analysis 
2.3.1 Extraction of total protein and quantification 
The total proteins were extracted by using Cytobuster Protein Extraction 
Reagent (Novagen, CA, USA). The tissues and cells were homogenized in 2 ml 
Cytobuster Protein Extraction Reagent. The mixtures were incubated at room 
temperature for 10 minutes and then centrifuged at 15,000 g at 4° C for 10 minutes. 
The supematants were collected and the protein concentrations were determined 
with the Protein Assay Dye Reagent (Bio-Rad, CA, USA). The protocol consisted of 
the addition of an acidic dye to protein solution, and followed by incubation of 10 
minutes and measurement at 595 nm with a spectrometer (Version 1.3，KCjunior, 
Bio-tek Instrument Inc., VT, USA). Relative measurement of protein concentration 
was interpolated with the 0.1-0.5 mg/ml BSA standard curve. 
2.3.2 Sodium Dodecyl-sulphate Polyacrylamide Gel Electrophoresis 
(SDS-PAGE) 
For the analysis of GHSR protein, one part of protein sample was mixed with 
two parts of laemmli sample buffer (Bio-Rad, CA, USA) containing 5 % 
p-mecaptoethanol. It was heat denatured at 97° C for 5 minutes. The protocol for 
SDS-PAGE was based on Laemmli's report [Laemmli 1970]. The type of 
electrophoresis is called discontinuous electrophoresis, consisting of two layers of 
gel. The upper layer called staking gel contained 4 % acrylamide allowing protein 
samples to be concentrated into staked bands before entering the lower layer, called 
separating gel with 12 % acrylamide. Apart from the difference in acrylamide 
concentration, they also contain 10 % SDS which is an anionic detergent. 
Polymerizing agent, ammomium persulfate (APS) and 
4 3 
N,N,N,-N'-tetramethylene-diamine (TEMED) were included in order to accelerate 
the polymerization of the gel. Heat denatured protein samples (20 ^ig/lane) were 
added to the gel for electrophoresis (Mini-PROTEAN III system, Bio-Rad, CA, 
USA) at 50 volts. After the dye front reached the top of the separating gel, the 
voltage was increased to 110 volts for further 1.5 hour. 
2.3.3 Tricine Sodium Dodecyl-sulphate Polyacrylamide Gel Electrophoresis 
(Tricine-SDS-PAGE) 
Tricine, used as the trailing ion, allows a resolution of small proteins at lower 
acrylamide concentrations than in glycine-SDS-PAGE systems. A superior 
resolution of small proteins, especially in the range between 5 and 20 kDa, could be 
achieved. For the analysis of ghrelin protein with a molecular size of 3.3 kDa, one 
part of protein sample was mixed with two parts of Tricine sample buffer (Bio-Rad, 
CA，USA) containing 5 % p-mecaptoethanol (Bio-Rad, CA, USA). It was heat 
denatured at 9 7 � C for 5 minutes. The protocol for Tricine-SDS-PAGE has been 
previously reported in detail [Schagger and von Jagow 1987]. The type of 
electrophoresis is called discontinuous electrophoresis, comprising three layers of 
gel. The upper layer called staking gel contained 4 % acrylamide allowing protein 
samples to be concentrated into staked bands before entering the middle layer, 
spacer gel with 10 % acrylamide and the lower gel, separating gel with 16.5 % 
acrylamide. Heat denatured protein samples (100 ^ig/lane) were added to the gel for 
electrophoresis (Mini-PROTEAN III system, Bio-Rad, CA, USA) at 50 volts. After 
the dye front reached the top of the spacer gel, the voltage was increased to 110 volts 
for further 2 hours. 
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2.3.4 Electroblotting and immunodetection of proteins 
The SDS-PAGE gel was equilibrated in electroblotting buffer (48 mM Tris/ 39 
mM glycine containing 20 % methanol) for 30 minutes [Lam and Leung 2003; Chan 
et al, 2000] while the Tricine- SDS-PAGE gel was equilibrated in electroblotting 
buffer for 5 minutes for 3 times, preventing the diffusion of small proteins from the 
gel. For SDS-PAGE gel, protein was immobilized on 0.45 micron polyvinylidene 
difluoride (PVDF) membrane (Micron, USA), while 0.2 micron PVDF membrane 
was used for Tricine-SDS-PAGE gel. PVDF membranes was first immersed in 
methanol for 15 seconds, followed by equilibrated in electroblotting buffer for 30 
minutes. Electroblotting was conducted by Semi-Dry Transfer System (Bio-Rad, CA, 
USA) at 15 volts for 30 minutes. 
For ghrelin protein, the membrane was immediately immersed in PBS 
containing 0.5 % (v/v) glutaraldehyde (Sigma-Aldrich, MO, USA) for 5 minutes, 
which was then moved to a fresh PBS/glutaraldehyde for 10 minutes [Karey and 
Sirbasku 1989]. To stop the cross-linking reaction, it was placed in PBS containing 
50 mM glycine and finally washed once with Tris-buffer saline (TBS: 25 mM 
Tris-HCl, 150 mM NaCl, 0.2 % Tween-20). 
For both ghrelin and GHSR protein, the membranes were blocked in 5 % 
skimmed milk in 20 ml TBS for 1 hour at room temperature [Lam and Leung 2003; 
Leung et al 2000b; Chan et al 2000]. The membranes were then sequentially 
incubated in rabbit anti-rat GHSR IgG (Alpha Diagnostic, TX, USA) at 1:200 or 
rabbit anti-rat ghrelin serum (Phoenix Pharmaceuticals, CA, USA) at 1:400 
overnight at 4° C. The GHSR specificity was tested by preadsorption of primary 
antisera with its excess homologus antigen, preincuated at 37° C for 30 minutes. 
After washing twice with TBS, the membranes were incubated with 
peroxidase-labelled anti-rabbit IgG (Boehringer Mannheim, Germany) at 1:1500 for 
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1 hour at room temperature. After thorough washing, the immunocomplexes were 
visualized with ECL-Plus Western blotting detection reagents (Amersham, NJ, USA) 
and autoradiography film. 
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2.4 Immimocytochemistry 
2.4.1 Preparation of isolated acinar cells for paraffin sections 
The procedure of preparation of paraffin sections was described previously in 
detail [Tsang et al 2004]. The isolated pancreatic acinar cells were fixed with 4 % 
paraformaldehyde (PFA) in 0.1 M PBS for 24 hours at room temperature. The 
PFA-treated cells were further processed with repeated sequential dehydration in a 
graded alcohol series and xylene clearing procedures. Processed samples were 
embedded in molten paraffin and cast into blocks after cooling. The 
paraffin-embedded blocks were sectioned onto 5-|im-thick polysine slices, and 
allowed to dry. The slides were de-paraffinized with incubation at 50° C for 15 
minutes, followed by immersed in xylene for 10 minutes for 3 times and hydrated 
with 99 o/o, 90 %, 80 % and 70 % ethanol in series for 3 minutes each. The sections 
were rinsed with PBS for 10 minutes. 
2.4.2 Preparation of AR42J cells slices 
As AR42J cells grow in cluster, the cluster of cells had to be dissociated gently 
into single cells by syringe with 18 G needle. Thereafter, the single AR42J cells 
were planted on a polysine slides for 4 hours at 37° C for attachment. The slides 
were fixed with 4 % PFA at 4° C for 8 minutes and then washed by PBS for 3 times. 
2.4.3 Immunofluorescent double staining 
Both sections of isolated acinar cells and AR42J cells were incubated with 4 % 
normal goat serum (Jackson, PA, USA) at 37° C for 30 minutes before indirect 
immunofluorescence double staining [Lam and Leung 2002]. All slides were 
incubated overnight at 4° C with goat anti-amylase polyclonal IgG (Santa Cruz, CA, 
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USA) at 1:150 dilution, together with either rabbit anti-ghrelin receptor polyclonal 
IgG (Santa Cruz, CA, USA) at 1:50 dilution or rabbit anti-ghrelin serum (Phoenix 
Pharmaceuticals, CA, USA) at 1:150 dilution. Thereafter, the slides were washed 
with PBS for 5 minutes for 3 times and incubated with secondary antibodies specific 
for rabbit (Cy3) (Jackson, PA, USA) at 1:100 dilution and for goat, 
Aminomethylcoumarin Acetate (AMCA) (Jackson, PA, USA) at 1:150 dilution for 1 
hour at room temperature. The specificity of immunostaining was validated either by 
preadsorption of primary antiserum with excess control peptide for GHSR, which 
was preincubated at 37° C for 30 minutes or by omission of primary antibodies for 
ghrelin. 
4 8 
2.5 Functional studies of digestive enzyme secretion from pancreatic isolated 
acini and lobules 
2.5.1 Incubation of pancreatic isolated acini and lobules with different peptides 
The procedure of functional studies of ghrelin was modified according to 
previous report [Tsang et al 2004a]. The isolated pancreatic acinar cells were 
re-suspended in 20 ml of incubation medium, adjusted to pH 7.35，which is similar to 
KHB but containing 10 mM HEPES and without bicarbonate addition. Moreover, 0.3 
mM phenylmethylsufonyl fluoride (PMSF) and 2 mM EDTA were also added to the 
incubation medium in order to suppress pancreatic proteases. The incubation medium 
containing 2000 mg/L glucose served as the metabolic substrate, was oxygenated 
with 95 % oxygen for 5 minutes. 3 ml of the acinar suspension was then transferred to 
each incubation vial for the study of enzymatic secretion. On the other hand, the 
pancreatic lobules were evenly distributed to each incubation vial, containing 3 ml of 
incubation medium. 
At the beginning of the 30-minute incubation period, 0.5 ml of acinar 
suspension was transferred out from each vial and subjected to a centrifugation at 
5000 rpm at 4° C for 2 minutes, while 0.5 ml of medium was transferred from vial 
containing lobules. To stop the reaction, all tubes were immediately put on ice. 
For the direct effects of the peptides in isolated acinar cells, 25 jil of the 
peptides: CCK (Sigma-Aldrich, MO, USA); carbachol (Calbiochem, CA, USA); 
ghrelin (Neosystem, France) at different concentrations were added to the incubation 
vials. The final concentration of each peptide was to 10"^  M CCK-8, to 
10-7 M carbachol and to 10"^  M ghrelin. 
In the co-incubation experiments with ghrelin in isolated acinar cells, different 
concentrations of CCK or carbachol were added with ghrelin to the incubation vials. 
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To test the effect of ghrelin with co-incubation of CCK-8, dispersed acinar cells 
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were incubated with two doses of ghrelin, 10" and 10" M, co-incubated with two 
doses of CCK-8, 10"^ ° and 10"^  M respectively. In addition, co-incubation of 
carbachol in a wide range of concentration, to 10"^  M, with a concentration 10'^  
M of ghrelin was performed. In the co-incubation with 75 mM potassium chloride 
experiments, to 10"^  M ghrelin were added with 75 mM potassium chloride in 
pancreatic lobules. After addition of peptides, the samples were incubated in a 37° C 
water bath with gentle shaking for 30 minutes. At the end of incubation, another 0.5 
ml of acinar suspension was taken from each vial, and which was subjected to 
centrifugation while another 0.5 ml of medium was taken from vial containing 
lobules. The supernatant was saved for analysis of a-amylase. 
2.5.2 Quantification of protein content 
Prior to the centrifugation of the 0.5 ml of acinar suspension transferred out 
from the incubation vial, 4 \i\ of the cell suspension was mixed with 200 jil of the 
Protein Assay Dye Reagent (Bio-Rad, CA, USA) in a micro-plate, and followed by 
incubation of 10 minutes in order to determine the protein content in each 
suspension vial. Measurement at 595 nm with a spectrometer (Version 1.3, KCjunior, 
Bio-tek Instrument Inc., VT, USA) was calibrated with the 0.1-0.5 mg/ml BSA 
strandard curve in order for calculating the protein concentration. The protein 
quantification assay was done with triplicate sets of measurements. 
2.5.3 Measurement of a-amylase secretion by a-amylase assay 
The secretion of a-amylase in the incubated samples was expressed as the rate 
of the enzymatic release during the incubation. The changes in absorbance 
throughout the 30-minute incubation were used to calculate the rate of release, i.e., 
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reading taken at time 0 was subtracted from the reading taken at time 30. The 
reading taken at time 0 was considered as the basal value of enzyme secretion. The 
activity of a-amylase was measured with an a-amylase assay kit according to 
manufactory manual (ThermoTrace, Australia), which was modified by our 
laboratory [Tsang et al 2003]. Briefly, the activity was measured based on the 
hydrolytic rate of a-amylase in hydrolysis of the substrate 
4,6-ethylidene-G7-p-nitrophenol to G2，G3 and G4 fragments and further to 
/7-nitrophenol and glucose, using a kinetic spectrophotometric method. The reaction 
started once 100 |il of the substrate reagent at 37° C was added to 2.5 ji l of sample. 
The increase in light absorbance of p-nitrophenol at 405 nm in a 2-minute period 
was taken with the micro-plate reader (Version 1.3, KCjunior, Bio-tek Instrument 
Inc., VT, USA). The rate of increase was calculated and the enzyme activity was 
expressed as fold of control. 
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2.6 Spectrofluorimetric measurement 
2.6.1 Incubation of AR42J cells with Fluo-4/AM 
AR42J cells were seeded on a cover-slip overnight prior to the Ca^^  
mobilization assay. Cells were then loaded with 3 |iM of Fluo-4 AM (Molecular 
Probes, OR, USA) in modified Hanks' balanced salts solution (HBSS: 1.26 mM 
CaCb, 5.33 mM KCl, 0.44 mM KH2PO4, 0.5 mM MgCb, 0.41 mM MgSC^，138 
mM NaCl, 4 mM NazHPCU，20 mM HEPES and 0.1 % glucose) containing 2.5 mM 
probenecid (Sigma-Aldrich, CA, USA) and 0.01 % pluronic F127 (Molecular 
Probes, OR, USA) at 37° C for 1 hour in the dark. After three washes with BBSS, 
the cells were further incubated in HBSS at 37° C for 15 minutes. 
2.6.2 Pretreatment of antagonist or blockers and Ca^^-free treatment 
In experiments demonstrating the inhibitory effects of the antagonist or IP3 
blockers, AR42J cells were preincubated with either (D-Lys^)-GHRP-6 (100 jiM) 
(Calbiochem, CA, USA), 2-APB (100 ^iM) (Calbiochem, CA, USA) [Maruyama et 
al 1997] or xestospongin C (3 |aM) (Calbiochem, CA, USA) [Gafni et al 1997] at 
37° C for 30 minutes in the dark, followed by stimulation with ghrelin (10"^  M). The 
novel membrane-penetrable modulator, 2-APB, inhibited Ins(l,4,5)P3-induced Ca^^  
release without affecting [3H]Ins(l,4,5)P3 binding to its receptor. The specificity of 
2-APB with respect to the intracellular signalling system was not fully established. 
On the other hand, xestospongin C is potent blockers of IPs-mediated Ca^ "^  release 
from endoplasmic reticulum vesicles, which blocks IPs-induced Ca^^  release without 
interacting with the IPs-binding site, suggesting a mechanism that is independent of 
the IP3 effector site. Xestospongin C represents a potent, membrane permeable IP3 
receptor blockers exhibiting a high selectivity. For external Ca^^-free experiments, 
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CaCl2 was omitted in HBSS and replaced by 2 mM EGTA that is a chelating agent 
for calcium. 
2.6.3 Calcium mobilization assay 
The excitation wavelength of 488 run was provided by an MRC-1000 Laser 
Scanning Confocal Imaging System (Bio-Rad, CA, USA) and the emitted 
fluorescence signals were detected at 515 nm. Data analyses were performed with 
MetaFluor (Version 2.0，Universal Imaging) [Kwan et al. 2003]. The responses of 
[Ca2+]i were displayed as the increase of Fluo-4 signal in arbitrary units. 
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2.7 Statistics and data analysis 
All gel images from RT-PCR and Western blotting were analyzed and 
quantified by an UV illuminator (FluroChem 8000 Advanced Fluorescence, 
chemiluminescence and Visible Light Imaging, Alpha Innotech Corporation, USA). 
The relative ghrelin and GHSR gene expression are normalized by the expression of 
GADPH and p-actin for the semi-quantitative RT-PCR. The results are expressed as 
means 土 S.E.M for six separate experiments. Relative expression of GHSR protein 
was expressed as % of control. The results are expressed as means 士 S.E.M for four 
separate experiments. Statistical comparisons and differences between mean values of 
normal and treated group were compared using unpaired Student's t-test. The data 
were considered statistically significant at 户 < 0 . 0 5 . 
For the measurement of pancreatic secretions of a-amylase, all data were 
expressed as mean 土 SEM from four or more independent measurements. The data 
were considered statistically significant at P<0.05, analyzing with one-way ANOVA 
followed by Tukey's multiple comparison test. 
Fluorescence studies evaluated at least 10 cells in each experiments. 
Fluorescence change values indicated were calculated as the difference between 
peak fluorescence value and the basal level. Results were expressed as means 土 
SEM of four or more experiments for all groups. For all comparisons,户<0.05 was 
considered statistically significant, using either unpaired t-test or one-way ANOVA 
followed by Tukey's multiple comparison test. 
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Chapter 3 Results 
3.1 Evidence for the existence of ghrelin system 
As a first step to demonstrate the presence of ghrelin system in the exocrine 
pancreas, expression and precise localization of ghrelin and its receptor in acinar 
cells and the AR42J cell line were attempted. Results from RT-PCR, Western blot 
and immunocytochemistry consistently showed the evidence for the existence of 
ghrelin system in exocrine pancreas. 
3.1.1 Expression of ghrelin and ghrelin receptor mRNA 
To identify ghrelin and ghrelin receptor mRNAs, RT-PCR coupled with 
specific primers for ghrelin and GHSR were performed to see whether they are 
present in the rat pancreatic acinar cells and AR42J cell line as well. 
Assessment of ghrelin mRNA expression by RT-PCR analysis demonstrated 
persistent expression of the gene in AR42J cells and in the pancreas, with the 
expression of a single PGR product with 321 bp (Fig. 3-1). The rat stomach, being 
the most ghrelin abundant tissue, was used as a positive control for ghrelin 
expression. No bands were detected in negative control of PGR using mRNA as 
template directly, confirming no contamination of genomic DNA. 
Expression of the mRNA encoding the GHSR was also evaluated by RT-PCR 
using a specific primer pair. Such an analysis demonstrated persistent expression of 
ghrelin receptor in pancreas, isolated acinar cells as well as AR42J cells, as indicated 
by a single PGR product of 313-bp (Fig. 3-2). The rat pituitary sample was used as a 
positive control for GHSR expression. No bands were amplified in negative control 
of PGR using mRNA as template directly, indicating no contamination of genomic 
DNA. 
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Figure 3-1. RT-PCR analysis of ghrelin mRNA in rat and AR42J cells. Lane M, 100 
bp DNA marker; Lane 1, negative control of using acinar cells mRNA 
as template directly; Lane 2, negative control of using AR42J cells 
mRNA as template directly; Lane 3, isolated acinar cells; Lane 4, 
AR42J cells; Lane 5, rat pancreas; Lane 6, rat stomach. The expected 
size of PGR products from ghrelin is 234 bp. 
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Figure 3-2. RT-PCR analysis of GHSR mRNA in rat and AR42J cells. Lane M, 100 
bp DNA marker; Lane 1, negative control of using acinar cells mRNA 
as template directly; Lane 2, negative control of using AR42J cells 
mRNA as template directly; Lane 3，isolated acinar cells; Lane 4， 
AR42J cells; Lane 5, rat pancreas; Lane 6, rat pituitary. The expected 
size of PGR products from GHSR is 313 bp. 
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3.1.2 Expression of ghrelin and ghrelin receptor protein 
In order to study the expression of the ghrelin and GHSR at the protein level, 
SDS-PAGE, Tricine-SDS-PAGE and Western blot analysis were performed on the 
extracted protein of rat acinar cells and AR42J cell line. 
In Western blot analysis of ghrelin protein, a single band was detected at 
approximately 3 kDa in the extract from rat pancreas, isolated acinar cells and 
AR42J cells (Fig. 3-3). This molecular size was in close agreement with the 
n-octanoylated mature 28-amino acid ghrelin peptide. On the other hand, the rat 
stomach, as the positive control of ghrelin, also exhibited consistently high 
expression. 
In addition, GHSR protein was consistently detected with a molecular size of 
46 kDa in pancreas, isolated acinar cells and AR42J cells as demonstrated by 
Western blot analysis (Fig. 3-4). Since the calculated molecular weight of the rat 
GHSR is about 41 kDa, this discrepancy could be explained by glycosylation of the 
molecule. The rat pituitary sample was also highly expressed for GHSR, which was 
used as positive control in the experiment. 
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Figure 3-3. Western blot analysis for ghrelin of Tricine-SDS-PAGE separated 
proteins in rat and AR42J cells. Lane 1, isolated acinar cells; Lane 2, 
AR42J cells; Lane 3, rat pancreas; Lane 4，rat stomach; Lane 5, 0.1 
|ig ghrelin peptide. The expected size of ghrelin protein is 3.3 kDa. 
Single bands of molecular size about 3 kDa were detected for ghrelin 
in all samples. 
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Figure 3-4. Western blot analysis for GHSR of SDS-PAGE separated proteins in rat 
and AR42J cells. Lane 1, negative control of the pre-adsorbed acinar 
cells; Lane 2, negative control of the pre-adsorbed AR42J cells; Lane 3, 
isolated acinar cells; Lane 4, AR42J cells; Lane 5, rat pancreas; Lane 6, 
rat pituitary. The expected size of GHSR protein is 41 kDa. Single 
bands of molecular size about 46 kDa were detected for GHSR. 
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3.1.3 Localization of ghrelin and ghrelin receptor protein 
The precise localization of ghrelin and GHSR was then studied by 
immimocytochemistry using specific antibodies against the purified protein in rat 
isolated acinar cells and AR42J cell line. 
Distinct immunoreactivity for ghrelin appears to be localized exclusively in rat 
acinar cells (Fig. 3-5) and AR42J cells (Fig. 3-6) as evidenced by double staining of 
ghrelin and amylase. Immunoreactivity for amylase, which was used as a positive 
immimocytochemistry marker for pancreatic exocrine acinar cells, was observed in 
acinar cells and AR42J cell line. Co-localization was confirmed by the overlay of 
image for both ghrelin and amylase. The specificity of immunoreactivity was 
validated by the omission of respective primary antibody. 
In addition, double immimostaining was also employed for precise localization 
of GHSR in rat acinar cells (Fig. 3-7) and AR42J cells (Fig. 3-8). The localization of 
GHSR and amylase in acinar cells and AR42J cells was identified by an overlay of 
immunoreactivity for amylase and GHSR. Specificity of the immunoreactivity was 
validated by the control experiment in which preadsorption of the primary antibody 
with excess control receptor peptide was conducted. 
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Figure 3-5. Immimocytochemical localization of ghrelin and amylase in isolated rat 
acinar cells. Distinct immunoreactivity for amylase (blue) (A) and 
ghrelin (red) (B) was localized to acinar cells. (C) Immunoreactivity for 
ghrelin was co-localized with amylase (purple). (D) No 
immunostaining was observed in omission of primary antibody in 
negative control. Magnification: 20 x Bar=150 |im. 
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Figure 3-6. Immunocytochemical localization of ghrelin and amylase in AR42J 
cells. Distinct immunoreactivity for amylase (blue) (A) and ghrelin 
(red) (B) was localized to AR42J cells. (C) Immunoreactivity for 
ghrelin was co-localized with amylase (purple). (D) No 
immunostaining was observed in omission of primary antibody in 
negative control. Magnification: 40 x Bar=50 \xm. 
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Figure 3-7. Immunocytochemical localization of GHSR and amylase in isolated rat 
acinar cells. Distinct immunoreactivity for amylase (blue) (A) and 
GHSR (red) (B) was localized to acinar cells. (C) Immunoreactivity for 
GHSR was co-localized with amylase (purple). (D) No immimostaining 
was observed in preadsorption of primary antibody with excess of 
GHSR antigen in negative control. Magnification: 20 x Bar=150 jam. 
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Figure 3-8. Immunocytochemical localization of GHSR and amylase in AR42J 
cells. Distinct immunoreactivity for amylase (blue) (A) and GHSR 
(red) (B) was localized to AR42J cells. (C) Immunoreactivity for 
GHSR was co-localized with amylase (purple). (D) No immunostaining 
was observed in preadsorption of primary antibody with excess of 
GHSR antigen in negative control. Magnification: 40 x Bar=50 \im. 
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3.2 Regulation of ghrelin system in exocrine pancreas 
As evidenced by the previous section, ghrelin system was unequivocally 
expressed in rat acinar cells. Accordingly, the effects of a number of stimuli: gastric 
acid inhibition, acute pancreatitis and starvation on the expression of ghrelin and 
GHSR in rat acinar cells were investigated. 
3.2.1 Validation and determination of RT-PCR conditions 
It is essential to validate the PGR conditions before the mRNA expression of 
ghrelin and GHSR in pancreatic acinar cells could be properly studied. The 
conditions were optimized based on the cycle number for both housekeeping genes: 
GADPH and P-actin as well as the cycle number for both target genes: ghrelin and 
GHSR. 
Results from optimization of ghrelin and its receptor as well as GADPH and 
P-actin exhibited that the PGR amplification can be divided into three phases: the 
initial phase, the exponential phase and the plateau phase (Fig. 3-9). From the graph, 
the cycle numbers for GADPH and p-actin amplification were chosen at 27 cycles 
and 28 cycles respectively, which were within the exponential phase of the 
amplification (Fig. 3-9A). Similarly, the cycle numbers for ghrelin and GHSR 
amplification were chosen at 33 cycles, which were also within the exponential 
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Figure 3-9. Validation of PCR conditions for ghrelin and GHSR regulation 
expression studies. A. The kinetics studies of PCR products for 
GADPH ( • ) and p-actin (〇）amplifications using isolated acinar 
cells cDNA as template. B. The kinetics studies of PCR products for 
ghrelin ( • ) and GHSR ( • ) amplifications using isolated acinar cells 
cDNA as template. 
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3.2.2 Effect of gastric acid inhibition on the expression of ghrelin and ghrelin 
receptor 
The mRNA expression of ghrelin and GHSR was investigated using RT-PCR 
in conjunction with specific primers in acinar cells. The mRNA expression of 
ghrelin was not significantly changed in the omeprazole-induced gastric acid 
inhibition when compared with the respective control as demonstrated by RT-PCR 
(Fig. 3-10). Conversely, the mRNA expression of GHSR in acinar cells was 
significantly upregulated, whereas the expression levels of p-actin remained 
unchanged when compared with the control (Fig. 3-11 A). Both house-keeping genes, 
GADPH and p-actin, were used for the normalization of expression. The result 
normalized with GADPH was consistent with that of p-actin (data not shown). The 
relative expression of mRNA for GHSR to p-actin in gastric acid inhibition was 
upregulated by about two-fold when compared with their respective controls, as 
demonstrated by RT-PCR and image analysis (Fig. 3-1 IB). 
To further elucidate the change of GHSR in protein expression, immunoblot 
analysis was performed. A predominant protein band of about 46 kD was 
consistently detected in acinar cells from both omeprazole-induced group and the 
control group. Under gastric acid inhibition, GHSR protein expression was increased 
significantly when compared to the respective control (Fig. 3-12A). There was a 
consistent increase of about 50 % of the relative expression of GHSR in the gastric 
acid inhibition group, as demonstrated by image analysis (Fig. 3-12B). 
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Figure 3-10. A. RT-PCR analysis of ghrelin mRNA by omeprazole-induced gastric 
acid inhibition in the rat acinar cells. Lane M, 100 bp DNA marker; 
Lane 1, P-actin (expected size= 240 bp) expression in control; Lane 2, 
p-actin expression in omeprazole-induced acinar cells; Lane 3, 
ghrelin (expected size= 234 bp) expression in control; Lane 4, ghrelin 
expression in omeprazole-induced acinar cells. B. The relative 
expression of ghrelin/p-actin mRNA in gastric acid inhibition 
compared with the respective control. The results are expressed as 
means 土 S.E.M for six separate experiments. P = 0.0758. 
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Figure 3-11. A. RT-PCR analysis of GHSR mRNA by omeprazole-induced gastric 
acid inhibition in the rat acinar cells. Lane M, 100 bp DNA marker; 
Lane 1, P-actin (expected size= 240 bp) expression in control; Lane 2, 
p-actin expression in omeprazole-induced acinar cells; Lane 3, GHSR 
(expected size= 313 bp) expression in control; Lane 4, GHSR 
expression in omeprazole-induced acinar cells. B. The relative 
expression of GHSR/p-actin mRNA in gastric acid inhibition 
compared with the respective control. The results are expressed as 
means 士 S.E.M for six separate experiments. < 0.05. 
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Figure 3-12. A. Western blot analysis of GHSR protein expression by 
omeprazole-induced gastric acid inhibition in the rat acinar cells. A 
major band of about 46 kDa was detected; B. The relative expression 
of GHSR protein in gastric acid inhibition compared with the 
respective control. The results are expressed as means 土 S.E.M for 
four separate experiments. ***户 < 0.001. 
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3.2.3 Effect of acute pancreatitis on the expression of ghrelin and ghrelin 
receptor 
The mRNA expression of both ghrelin and GHSR in acinar cells were 
investigated using RT-PCR in conjunction with specific primers. There was no 
significant change in the mRNA expression for the ghrelin the acute pancreatitis 
when compared with the respective control (Fig. 3-13). In contrast, a marked 
decrease of the mRNA expression for GHSR was observed in acinar cells, whereas 
the expression levels of GADPH remained unchanged when compared with the 
control (Fig. 3-14A). Both house-keeping genes, i.e. GADPH and P-actin, were used 
for normalization. The result normalized with p-actin was consistent with that of 
GADPH (data not shown). The relative expression on mRNA for GHSR to GADPH 
in acute pancreatitis was downregulated by about one-fourth when compared with 
the control (Fig. 3-14B). 
In parallel with the mRNA level, the expression change of GHSR protein by 
acute pancreatitis was also markedly decreased when compared with the control as 
demonstrated by Western blot analysis (Fig. 3-15A). A predominant protein band of 
about 46 kD was consistently detected both in acute pancreatitis and the control 
acinar cells. The relative level of changes by acute pancreatitis was about one-fourth 
as demonstrated by image analysis (Fig. 3-15B). 
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Figure 3-13. A. RT-PCR analysis of ghrelin mRNA by acute pancreatitis in the rat 
acinar cells. Lane M, 100 bp DNA marker; Lane 1, GADPH 
(expected size= 309 bp) expression in control; Lane 2, GADPH 
expression in acute pancreatitis acinar cells; Lane 3, ghrelin (expected 
size= 234 bp) expression in control; Lane 4, ghrelin expression in 
acute pancreatitis acinar cells. B. The relative expression of 
ghrelin/GADPH mRNA in acute pancreatitis compared with the 
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Figure 3-14. A. RT-PCR analysis of GHSR mRNA by acute pancreatitis in the rat 
acinar cells. Lane M, 100 bp DNA marker; Lane 1, GADPH 
(expected size= 309 bp) expression in control; Lane 2，GADPH 
expression in acute pancreatitis acinar cells; Lane 3, GHSR (expected 
size= 313 bp) expression in control; Lane 4, GHSR expression in 
acute pancreatitis acinar cells. B. The relative expression of 
GHSR/GADPH mRNA in acute pancreatitis compared with the 
respective control. The results are expressed as means 土 S.E.M for six 
separate experiments. < 0.01. 
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Figure 3-15. A. Western blot analysis of GHSR protein expression by acute 
pancreatitis in the rat acinar cells. A major band of about 46 kDa was 
detected; B. The relative expression of GHSR protein in acute 
pancreatitis compared with the respective control. The results are 
expressed as means 土 S.E.M for four separate experiments. ***P < 
0.001. 
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3.2.4 Effect of starvation on the expression of ghrelin and ghrelin receptor 
On the other hand, starvation had no effect on the ghrelin and GHSR 
expression. There was no significant change in the mRNA expression for the ghrelin 
(Fig. 16A) and GHSR (Fig. 16B) in 72-hour starvation when compared with the 
respective control Again, the expression levels of GADPH remained unchanged 
when compared with the control. Both house-keeping genes, GADPH and p-actin, 
were used for the normalization of expression. The result normalized with p-actin 
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Figure 3-16. A. The relative expression of ghrelin/GADPH mRNA in the rat acinar 
cells in 72-hour starvation in RT-PCR analysis. B. The relative 
expression of GHSR/GADPH mRNA in 72-hour starvation compared 
with the respective control in RT-PCR analysis. The results are 
expressed as means 土 S.E.M for six separate experiments. 
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3.3 Evaluation of ghrelin on enzyme secretion in acinar cells 
Activity of a-amylase in the freshly isolated pancreatic acinar cells was 
measured in order to investigate the direct effects of CCK-8, carbachol and ghrelin 
on the regulation of acinar digestive enzyme secretions. In addition, the 
co-incubation of CCK-8 or carbachol with ghrelin was also investigated in isolated 
acinar cells; the co-incubation of depolarizing concentrator! of KCl with ghrelin on 
pancreatic lobules was also demonstrated. 
3.3.1 Acinar secretions induced by cholecystokinin, carbachol, and ghrelin 
In the present study, the secretory function of the freshly dispersed pancreatic 
acinar cells was primarily examined in terms of their responsivenes to exogenous 
secretagogue CCK-8, which is the well-established hormone for stimulating exocrine 
secretion. The isolated pancreatic acinar cells were found highly functional as 
implicated by the extensive secretion of a-amylase after 30-minute incubation with 
CCK-8. The CCK-stimulated release of a-amylase from pancreatic acinar cells 
exhibited a concentration-dependent manner from to 10"^  M (Fig. 3-17A). 
Similar to the CCK-8 stimulation, exogenous addition carbachol, which is a 
cholinergic agonist, was also demonstrated to stimulate acinar secretion of digestive 
enzymes. The acinar secretion of a-amylase evoked by carbachol was also found to 
be dose-dependent from to 10"^  M (Fig. 3-17B). However, the stimulatory 
potency of carbachol was not as high as CCK-8. The half-maximal dose of carbachol 
was 10-8 M while that of CCK-8 was IQ-i。M (Fig. 3-17). 
Apart from CCK-8 and carbachol, exogenous administration of ghrelin was 
investigated in the isolated pancreatic acinar cells. However, a wide range of 
concentration of ghrelin from to 10"^  M did not exert any effect on a-amylase 
secretion after 30-minute incubation (Fig. 3-18). 
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Figure 3-17. A. Dosage dependent effects of CCK-8 from concentration to 10"^  
M on a-amylase secretion from isolated pancreatic acinar cells. B. 
Dosage dependent effects of carbachol from concentration to 
10-7 M on a-amylase secretion from isolated pancreatic acinar cells. 
The results are expressed as means 土 S.E.M for six separate 
experiments. < 0.01，< 0.001. 
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Figure 3-18. Addition of ghrelin from concentration ICT" to 10"^  M on a-amylase 
secretion from isolated pancreatic acinar cells in 30-minute 
incubation. The results are expressed as means 土 S.E.M for six 
separate experiments. 
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3.3.2 Co-incubation of cholecystokinin or carbachol with ghrelin 
To test the effect of ghrelin with co-incubation of CCK-8 on pancreatic 
exocrine function, dispersed acinar cells were incubated with two doses of ghrelin 
(10-8 肌d 10-7 M) and two doses of CCK-8 and 10'^  M)，respectively. The two 
doses of CCK chosen were the concentrations that stimulated the maximal and 
half-maximal response. However, ghrelin produced neither additive nor potentiative 
effects with CCK-8 in rat isolated acinar cells (Fig. 3-19). 
Similarly, co-incubation of carbachol in a wide range of concentration (10"'^ to 
10.7 M) with a concentration 10"^  M of ghrelin, produced no change in a-amylase 
release compared to that observed with carbachol alone (Fig. 3-20). 
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Figure 3-19. In vitro effects of ghrelin on CCK-8 stimulated a-amylase release from 
dispersed rat acinar cells. Acinar cells were incubated with 10'^  and 10'^  
M ghrelin in the presence of and 10"^  M CCK-8 in 30-minute 
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Figure 3-20. In vitro effects of ghrelin on carbachol stimulated a-amylase release 
from dispersed rat acinar cells. Acinar cells were incubated with 10"^  
M ghrelin with various concentration of carbachol, to 10'^  M, in 
30-minute incubation. The results are expressed as means 土 S.E.M for 
six separate experiments. 
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3.3.3 Co-incubation of potassium ions with ghrelin in pancreatic lobules 
Incubation of pancreatic lobules in a medium containing elevated 75 mM of 
potassium significantly increased a-amylase release. Ghrelin, at concentrations from 
IQ-ii to 10.7 M, dose-dependently decreased a-amylase release from pancreatic 
lobules exposed to potassium (Fig. 3-21). Ghrelin dose-dependently decreased 
a-amylase release when stimulated by depolarizing concentrator! of KCl in 
pancreatic lobules with intrapancreatic innervation. 
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Figure 3-21. In vitro effects of ghrelin in 75 mM potassium chloride-stimulated 
a-amylase secreted from rat pancreatic lobules. Pancreatic lobules 
were incubated with 75 mM potassium chloride with various 
concentration of ghrelin, 10''^  to 10"^  M, in 30-minute incubation. The 
results are expressed as means 土 S.E.M for six separate experiments. 
+++P < 0.001 vs. control; **P < 0.01, < 0.001 vs. K C I . 、 
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3.4 Calcium signalling of ghrelin on AR42J cells 
In previous section, the existence, regulations and potential role of ghrelin 
system have been demonstrated. In this section, its intracellular calcium signalling 
during ligand stimulation was further investigated using a pancreatic exocrine cell 
lineAR42J. 
3.4.1 Dose responsive response to CCK-8, ghrelin and ghrelin's agonist 
Addition of to 10"^  M CCK-8, to AR42J cells that express the CCK 
receptor induced a dose-dependent increase in [Ca2+]i. Application of 10"^  M CCK-8 
produced responses consisted of a transient rise (105 土 6.2 in arbitrary unit) 
and rapid return of to a sustained level in about 1 minute (Fig. 3-22). 
The AR42J cells also responded to ghrelin dose-dependently in the 10'^-10"^ 
M concentration range with consistently about 2-4 minutes delay response (Fig. 
3-23). Application of low dose, 10"^  M ghrelin elicited a small peak with a delay 
response for 4 minutes. From the concentrations of 10"^  to 10'^  M of ghrelin, the 
delay response is gradually diminished while the time to reach the peak response 
was also reduced. Application of 10'^  M ghrelin produced a prompt transient 
increase in (84.4 土 7.2 in arbitrary unit), followed by a slow decline to 
pre-stimulation levels of fluorescence. The plateau response was consistently 
observed after ghrelin application and more frequent with high concentration. This 
plateau response even presents 30 minutes after application of ghrelin (data not 
shown). 
The agonist of ghrelin, GHRP-6, induced the similar responses on 
AR42J cells to ghrelin (Fig. 3-24). The delayed response of GHRP-6 was more 
significant for several minutes in low concentrations. When 10"^  M GHRP-6 was 
applied, the biphasic response was induced. The first phase consisted in a 
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rapid large [CsL^ h^ transient (41.9 土 3.7 in arbitrary unit), followed by slow return to 
pre-stimulation levels of fluorescence lasted for several minutes. 
The 10-8 to 10-5 M GHRP-6-induced rise was dose-dependent with 
half-maximal response at 10"^  M (Fig. 3-25), being 10-fold less potent than ghrelin 
with half-maximal response at 5 x 10"^  M. Moreover, the [Ca2+]i changes of ghrelin 
(84.4 土 7.2 in arbitrary unit) was 2-fold more potent than GHRP-6 (41.9 土 3.7 in 
arbitrary unit). On the other hand, CCK-8 was most potent to AR42J cells with 
half-maximal response at M, being four orders of magnitude more potent than 
ghrelin. The responses of ghrelin and GHRP-6 at high concentration consist 
of biphasic pattern suggests that both ghrelin and GHRP-6 probably activate two 
distinct mechanisms for increase. 
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Figure 3-22. Effects of different concentrations of CCK-8 on 3 jiM 
Fluo-4/AM-loaded AR42J cells were incubated for 1 hour and 
stimulated with to 10"^  M CCK-8. Each addition was made to 
previously unstimulated cells. The tracings are representative of four 
different sets of experiments. 
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Figure 3-23. Ghrelin-induced calcium mobilization in AR42J cells. Cells were 
stimulated with 10'^  to 10'^  M ghrelin, and changes in [Ca^^Ji were 
measured with the fluorescent probe. 3 |iM Fluo-4/AM. Each addition 
was made to previously unstimulated cells. The tracings are 
representative of four different sets of experiments. 
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Figure 3-24. AR42J cells were stimulated with different concentrations of agonist, 
GHRP-6 from 10"^  to 10"^  M on [Ca2+]i and changes in [Ca2+]丨 were 
measured with the fluorescent probe. 3 |iM Fluo-4/AM. Each addition 
was made to previously unstimulated cells. The tracings are 
representative of four different sets of experiments. 
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Figure 3-25. Dose response of the effects of CCK-8, ghrelin and GHRP-6 on 
intracellular calcium mobilization in AR42J cells. The results are 
expressed as means 士 S.E.M. for 4 separated experiments. 
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3.4.2 Antagonistic blockade on ghrelin-induced [Ca^+h response 
To determine whether the effect of ghrelin was receptor mediated, experiments 
were performed with (D-Lys^)-GHRP-6, a specific antagonist of GHSR (Fig. 3-26). 
Pretreatment of AR42J cells with 100 \iM (D-Lys^)-GHRP-6 for 30 minutes at 37°C 
before application of 10"^  M ghrelin decreased the changes on response (16.5 
土 1.2 in arbitrary unit) compared with the response in control (84.4 土 7.2 in 
arbitrary unit) (Fig. 3-23). In control AR42J cells, 93 % of the cells (156 of 168) 
responded to ghrelin, while after pretreatment of AR42J cells with 
(D-Lys^)-GHRP-6, only 77 % of the cells (183 of 238) responded to ghrelin. In the 
presence of (D-Lys^)-GHRP-6, the increase in evoked by 10"^  M ghrelin was 
delayed for about 2 minutes. These results support the GHSR, mediating the effect 






k _ J 
5 80 -'(0 
I 60” 
I 40 - - 〜 
^ 个 
20 - I 
Ghrelin 10"® M 
———— 
0 5 1 
Time (min) 
Figure 3-26. Inhibitory effects of the antagonist (D-Lys^)-GHRP-6 on calcium 
transient evoked by 10"^  M ghrelin. AR42J cells were preincubated 
with 100 j iM (D-Lys3)-GHRP-6. In the presence of (D-Lys^)-GHRP-6, 
only 77 % of the cells responded to ghrelin compared with 93 % of 
responding cells in control. 
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3.4.3 The role of extracellular Ca^ ^ in ghrelin receptor-mediated response 
To investigate the role of extracellular for ghrelin-induced calcium 
mobilization in AR42J cells, the cells were incubated in Ca^^-free HBSS medium 
with 2 mM EGTA (Fig. 3-27). The stimulatory effect of ghrelin was markedly 
decreased in the absence of extracellular 土 1.9 in arbitrary unit). Only 14 
% of the cells (25 of 177) responded to ghrelin compared with 93 % responding cells 
in control. Among the 14 % of responding cells, the initial spike phase was 
maintained but greatly diminished while the sustained plateau phase was completely 
abolished. Replacing the external solution with one containing 2.5 mM calcium 
activated the calcium influx across plasma membrane. 
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Figure 3-27. Role of extracellular Ca^^  in ghrelin-induced increase in [Ca^"^]；. 
Inhibition of the response by application of Ca^^-free HBSS 
medium containing 2 mM EGTA. Only 14 % of the cells responded 
to 10_6 M ghrelin. 
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3.4.4 Effects of intracellular Ca^ ^ on ghrelin stimulated [Ca^+h elevation 
To investigate the involvement of intracellular Ca^ "^  stores in the action of 
ghrelin, the Ins(l,4,5)P3 receptor blockers, 2-APB (Fig. 3-28A) and xestospongin C 
(Fig. 3-28B) were applied. Pretreatment of the cells by either 2-APB (100 |iM) or 
xestospongin C (3 |j,M) significantly decreased the stimulatory effect of ghrelin (11.1 
土 1.1 and 10.3 土 1.7 in arbitrary unit respectively). Only 54 % of the AR42J cells 
responded to 1 M ghrelin in the presence of 2-APB and only 43 % of the cells 
responded to 10"^  M ghrelin in the presence of xestospongin C. In the presence of the 
blockers, the transient phase has abolished and there was only a slight increase in 
[Ca2+]i. 
In summary, AR42J cells, stimulated by 10"^  M ghrelin, were signicantly 
inhibited by either (D-Lys^)-GHRP-6, Ca^^-free, 2-APB or xestospongin C. It was 
demonstrated that both extracellular and intracellular Ca^^  play a role in stimulatory 
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Figure 3-28. Role of intracellular Ca^^  in ghrelin-induced increase in [Ca2+]i. A. The 
effects of the pretreatment of 100 |aM 2-APB on ghrelin 
response. 54 % of the AR42J cells responded to 10'^  M ghrelin. B. 
Pretreatment of AR42J cells with 3 xestospongin C inhibited the 
ghrelin-induced [Ca2+]i response. 43 % of the cells responded to 10"^  
M ghrelin. 
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Figure 3-29. Effect of (D-Lys^)-GHRP-6, Ca2+-free, 2-APB and xestospongin C on 
10.6 M ghrelin responses. Results are expressed as the fluorescence 
change values, indicating the difference between peak fluorescence 
value and the basal level. The tracings data are representative of eight 
different sets of experiments. < 0.001. 
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Chapter 4 Discussion 
4.1 Ghrelin system in acinar cells and AR42J cells 
Emerging evidence indicates that the role of ghrelin, as an endogenous ligand 
of the GHSR, is not only restricted to the physiological control of GH secretion, but 
also likely to involve in other additional endocrine, paracrine and autocrine actions 
in peripheral tissue organs. In the present work, we provided unequivocal evidence 
for the expression of ghrelin and its functional receptor, GHSR, in the rat pancreatic 
exocrine acinar cells as well as its corresponding cell line AR42J. 
It is well known that ghrelin is highly expressed in the mucosal layer of 
stomach [Date et al 2000a; Hosoda et al. 2000b]. Apart from stomach, ghrelin has 
been found to be produced by pituitary [Korbonits et al. 2001], hypothalamus 
[Horvath et al 2001]，intestine [Hosoda et al 2000b], placenta [Gualillo et al 2001], 
kidney [Mori et al 2000], heart [Wang et al 2002], leydig cells [Tena-Sempere et al 
2002], lung [Volante et al. 2002b], ovary [Gaytan et al. 2003], immune cells [Hattori 
et al 2001], liver and some tumor cells such as ectopic adrenocorticotropic hormone 
-secreting tumors, gastrinomas, insulinomas [Korbonits et al. 2001] and in human 
medullary thyroid carcinomas [Kanamoto et al 2001]. The widespread distribution 
of ghrelin suggests that ghrelin might have wide variety of physiological effects in 
these tissue organs. Like ghrelin, the ghrelin receptor, GHSR also has a widespread 
distribution, suggesting multiple paracrine, autocrine and endocrine roles for ghrelin. 
A number of reports demonstrated that the pancreas showed a low but 
detectable level of expression of ghrelin and GHSR [Kojima et al 1999; Korbonits 
et a/. 1999; Wang et al 2002; Gnanapavan et a/. 2002]. Some recent studies have 
further shown that ghrelin and ghrelin receptor were present in pancreatic endocrine 
islet cells [Wierup et aL2002; Date et al 2002; Korbonits et al 2001; Ambrogi et al 
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2003]. In addition, ghrelin was co-localized exclusively with glucagon in rat islets, 
indicating that ghrelin might be specifically produced in islet a-cells [Date et al. 
2002]. Our findings agree with the previous studies showing the existence of ghrelin 
and its receptor in pancreas. Furthermore, the present study is the first to show the 
existence of both ghrelin and GHSR at the gene (Fig. 3-1; Fig. 3-2) and protein 
levels (Fig. 3-3; Fig. 3-4) in the pancreatic exocrine cells. Identification of ghrelin 
and its receptor expression in exocrine pancreas was achieved by RT-PCR, Western 
blot analysis and immunocytochemical approaches. Our analyses demonstrated that 
ghrelin and GHSR mRNA were consistently expressed in rat pancreatic acinar cells 
and its AR42J cell line. By means of Western blot analysis, ghrelin and GHSR 
protein showed distinct expression in exocrine pancreas. Immunocytochemical 
staining provided further evidence for the localization of ghrelin and ghrelin 
receptor protein in pancreatic acinar cells (Fig. 3-5; Fig. 3-6) and AR42J cell line 
(Fig. 3-7; Fig. 3-8). Co-localization of ghrelin and its receptor with amylase in 
isolated acinar cells and AR42J cells indicates that ghrelin may have a potential role 
in regulating pancreatic exocrine actions, probably via the mediation of an autocrine 
and/or paracrine pathway. 
In this context, the potential functions of ghrelin in exocrine pancreas have 
been recently demonstrated. For example, pancreatic exocrine secretion was 
inhibited by ghrelin in anesthetized rats and in pancreatic lobules [Zhang et al 2001]. 
However, centrally administered ghrelin could stimulate pancreatic exocrine 
secretion through the vagal nerve in conscious rats [Sato et al 2003]. 
Notwithstanding the presence of these data, the potential role of ghrelin on enzyme 
secretion is still equivocal and controversal. Apart from that, administration of 
ghrelin could attenuate pancreatic damage in cerulein-induced pancreatitis 
[Dembinski et al 2003] and protective effect of ghrelin administration seemed to be 
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related to the inhibition in inflammatory process. Moreover, ghrelin also promoted 
pancreatic adenocarcinoma cellular proliferation and invasiveness [Duxbury et al 
2003]. 
The present study has unequivocally demonstrated the evidence for the 
existence of ghrelin and its receptor in pancreatic acinar cells. Such a ghrelin system 
may have a role in regulating the physiology and pathophysiology of the pancreas 
via the mediation of a paracrine and/or autocrine fashion. Nevertheless, it needs to 
be further investigated. 
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4.2 Regulation of the expression of ghrelin system 
The existence of ghrelin and GHSR expression in exocrine pancreas has been 
discussed in the previous section. Interestingly, it is known that the expression of 
ghrelin and GHSR was regulated by a number of physiological or 
pathophysiological factors. Some reports suggested that estrogen modulated ghrelin 
expression in the female rat stomach [Matsubara et al 2004] and GHRH treatment 
in rats increased pituitary ghrelin expression [Kamegai et al. 2001]. In addition, 
acute insulin administration has been shown to increase stomach ghrelin expression 
moderately in rats [Toshinai et al 2001]. Apart from the hormonal regulation, the 
ghrelin system was subjected to the changes by various factors. For example, the 
GHSR mRNA expression was subjected to developmental, stage-specific and 
hormonal regulation in rat testis [Barreiro et al 2003]. During fasting, stomach 
ghrelin and hypothalamic ghrelin receptor mRNA expression was upregulated [Kim 
et al 2003]. Furthermore, the levels of both ghrelin peptide and mRNA in the 
stomach were also upregulated in long-term negative energy balance of 
tumor-inoculated cachectic mice. [Hanada et al. 2004]. In pituitary GH-producing 
adenomas, GHSR mRNA was highly upregulated at a level of 200 times higher than 
the normal pituitary [Skinner et al 1998]. However, regulation of the expression of 
ghrelin and its receptor is still largely undefined. This prompts us to speculate the 
regulation of ghrelin system in the physiology of gastric acid inhibition and 
starvation as well as pathophysiology of acute pancreatitis in pancreatic acinar cells. 
In the present work, experimentally omeprazole-induced gastric acid inhibition 
did not cause a significant change in mRNA expression of ghrelin (Fig. 3-10), but a 
significant upregulation of in GHSR mRNA (Fig. 3-11) and protein (Fig. 3-12) as 
evidenced by semi-quantitative RT-PCR and Western blot analysis respectively. 
Omeprazole, an inhibitor of H+/K+-ATPase in secretory surface of gastric parietal 
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cells, is widely used to treat acid-related disorders [Langtry et al. 1998]. 
Omeprazole-induced achlorhydria is associated with hypergastrinemia, which has 
been reported to increase the weight of parathyroid gland and the gene expression of 
parathyroid hormone in both rats and chicken [Gagnemo-Persson et al 1994; 
Grimelius et al 1997]. Hypergastrinemia also produced trophic growth-promoting 
effect on the ECL cells in gastric oxyntic mucosa, but not in pancreas or intestines 
[Hakanson et al 1986; Hakanson et al 1988]. Nevertheless, treatment with 
omeprazole failed to affect the expression of ghrelin mRNA in ghrelin-containing 
A-like cells in oxyntic mucosa. This finding suggested that ghrelin might operate 
independently of gastrin [Domonville et al. 2001]. 
Consistent with the regulation of ghrelin in gastric oxyntic mucosa, the present 
results demonstrated the omeprazole-induced achlorhydria did not affect the 
expression of ghrelin mRNA in pancreatic exocrine acinar cells. Interestingly, 
treatment of omeprazole elicited a marked increase in GHSR mRNA and protein. In 
fact, the profound inhibition of gastric acid by omeprazole, being a H+/K+-ATPase 
blocker consequent in some potent side effects, such as the intragastric bacterial 
overgrowth [Mazzacca and Sabbatini 1990; Carlsson et al. 1986]. The bacterial 
overgrowth of the stomach causes the gut more susceptible to enteric infection and 
another possible consequence of intragastric bacteria is the formation of N-nitroso 
compounds with carcinogenic potency [Mazzacca and Sabbatini 1990; Powers et al 
1995]. Previous studies have shown that intraperitoneal administration of 
omeprazole caused acute inflammation thus leading to damage in peripancreatic 
lipid tissue. Moreover, it activated the elevation of some pancreatic lysosomal 
enzymes, which may be responsible for the initiation of inflammation [Burdan et al. 
2000]. Thus, it is plausible to speculate that omeprazole-induced achlorhydria has 
some physiological implications on the pancreas. However, its physiological and 
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clinical relevance on the pancreas have yet been investigated. It is therefore 
plausible to suggest that upregulation of GHSR expression (Fig. 3-11; Fig. 3-12) 
during achlorhydria may be important in the regulation of physiology in exocrine 
pancreas. However, the role of GHSR in the exocrine pancreas and its upregulation 
during gastric acid inhibition still remains to be elucidated. 
In addition to the physiological regulation by gastric acid inhibition, ghrelin 
system was also subjected to acute pancreatitis. Although cerulein-induced acute 
pancreatitis did not cause a significant change in mRNA expression of ghrelin (Fig. 
3-13), it caused a small but significant decrease in GHSR mRNA (Fig. 3-14) and 
protein (Fig. 3-15) by semi-quantitative RT-PCR and Western blotting. 
Acute pancreatitis is an inflammatory disease characterized by tissue edema, 
acinar necrosis, hemorrhage and fat necrosis as well as inflammation and 
perivascular infiltration in the pancreas [Schmidt et al. 1992]. The etiology of acute 
pancreatitis is believed to be multifactorial [Norman 1999; Agarwal and Pitchumoni 
1993]. One of the factors is the activation of vasoactive peptide, such as angiotensin 
I I [Leung et al 2000b]. The marked upregulation of pancreatic angiotensin II could 
play a crucial role in the induction of inflammation and in the impairment of 
microcirculatory regulation in the pancreas. It is believed that some factors leading 
to acute pancreatitis, which might be responsible for the downregulation of GHSR 
expression (Fig. 3-14; Fig. 3-15)，are undefined. Previous studies have demonstrated 
that ghrelin system has a potential role in pancreatic exocrine secretion. The 
pancreatic exocrine secretion was inhibited by ghrelin in anesthetized rats and in 
dispersed rat acinar cells [Zhang et al 2001] whereas centrally ICV administered 
ghrelin stimulates pancreatic exocrine secretion in conscious rats [Sato et al 2003]. 
The effects of ghrelin on exocrine secretion are still debatable. Thus, the association 
between hyperstimulation of proteolytic enzymes and differential change in GHSR 
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is unclear. Furthermore, administration of ghrelin attenuated pancreatic damage in 
cerulein-induced pancreatitis [Dembinski et al. 2003]. Hence, it is believed that 
ghrelin system may be relevant to the pathophysiology of acute pancreatitis in 
pancreas. In fact, the influence of acute pancreatitis on the pancreatic ghrelin system 
and its pathophysiological significance are far less clear. It might be probably due to 
the multiple functions of ghrelin in exocrine pancreas. The differential changes in 
GHSR could play a role in pathophysiology of acute pancreatitis. However, the 
potential association between differential changes in GHSR and acute pancreatitis 
needs further investigations. 
In regard of starvation, the regulations of ghrelin and its receptor expression in 
exocrine pancreas have been speculated. Nevertheless, 72-hour starvation of the rats 
did not cause any significant change in mRNA expression of both ghrelin (Fig. 
3-16A) and GHSR (Fig. 3-16B), by semi-quantitative RT-PCR. 
It is evident that ghrelin is an important regulator of appetite and food intake 
[Nakazato et al. 2001; Shuto et al 2002; Cummings and Shannon 2003a]. It is a 
potent orexigenic peptide that seems to participate in the adaptive response to weight 
loss [Cummings and Schwartz 2003b; Leibel et al 1995]. Some studies have 
demonstrated that plasma ghrelin was markedly elevated in patients with 
malnutrition due to several states of low food intake, such as anorexia [Otto et al 
2001], caloric restriction [Cummings et al 2002] and cancer cachexia [Wisse et al 
2001; Camina et al. 2003b]. Conversely, circulating ghrelin was reduced in obese 
individuals than the lean subjects and in response to over-feeding [Tschop et al. 
2001a]. In addition, the regulation of ghrelin system in molecular level has been 
further investigated. It has been already clear that the mRNA level of gastric ghrelin 
was markedly upregulated by food deprivation [Gualillo et al. 2002] and 
downregulated by food intake [Cummings et al 2001; Tschop et al. 2001a] in rats. 
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Moreover, stomach ghrelin mRNA levels and plasma ghrelin levels were increased 
in 72-hour fasted rats and decreased with re-feeding [Lee et al. 2002]. This rodent 
study also showed that a high-fat diet lowered stomach ghrelin mRNA expression 
[Lee et al. 2002]. Thus, it is believed that the effect of starvation on ghrelin system 
is significant in rat stomach. 
Although ghrelin expression was upregulated by starvation in rat stomach, 
both ghrelin and ghrelin receptor did not significantly alter in pancreatic exocrine 
acinar cells in 72-hour starved rats (Fig. 3-16). It suggested that the regulation of 
ghrelin expression in starvation might have a potential role in physiological and 
pathophysiological aspects of the stomach, but not in exocrine pancreas. 
In summary, the present studies provided an insight into regulated expression 
of ghrelin system by gastric acid inhibition, acute pancreatitis and starvation in 
exocrine pancreas. The gene and protein expression of GHSR was significantly 
upregulated in gastric acid inhibition whereas downregulated in acute pancreatitis, 
but no effects in starvation. However, there were no differential effects of gastric 
acid inhibition, acute pancreatitis and starvation on the expression of ghrelin. It is 
believed that the differential change in GHSR could play a role in the physiology 
and pathophysiology of the pancreas. However, the significance of its regulation 
remains undefined and merits further investigations. 
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4.3 Biological function of ghrelin on enzyme secretion in acinar cells 
The pancreatic exocrine secretion in response to meal is mediated by a 
complex interplay of neural and hormonal regulation. Classically, the stimulation of 
exocrine pancreatic secretion depends on numerous enterohormones, especially 
CCK and secretin, released by duodeno-jejunal mucosa and originally believed to 
act via an endocrine pathway [Bayliss and Starling 1902]. Recent findings have 
shown that some of the enterohormones such as CCK, pancreatic polypeptide, 
peptide YY, neuropeptide Y and somatostatin, exert their biological actions via a 
neuroendocrine pathway [Edkins 1902; Nathan and Liddle 2002]. It supports for the 
concept of neuroendocrinology of the digestive system [Pavlov 1910]. In this study, 
a regulation of pancreatic exocrine secretion occurs at different levels, including 
direct hormonal effect via receptors on acinar cells and intrapancreatic neurons in 
pancreatic lobules in vitro were under investigations. 
In the present study, it is first to speculate the direct hormonal effect of the 
ghrelin on pancreatic exocrine function. Dispersed acinar cells were primarily 
examined in terms of their responsivenes with various doses of exogenous 
secretagogue CCK-8 and carbachol in vitro. As expected, CCK-8, which is the 
well-established hormone for stimulating exocrine secretion, stimulated the release 
of a-amylase from pancreatic acinar cells in a concentration-dependent manner from 
10-12 to 10.9 M (Fig. 3-17A). In addition, exogenous administration of carbachol, 
which is a cholinergic neurotransmitter, was also demonstrated to stimulate acinar 
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secretion of digestive enzymes dose-dependently from 10" to 10' M (Fig. 3-17B). 
These results supported that the isolated pancreatic acinar cells from the present 
study were highly functional as implicated by the extensive secretion of a-amylase 
after a 30-minute incubation with CCK-8 and carbachol. These data confirm that 
both hormonal and neural regulators, CCK-8 and carbachol, are potent stimuli for 
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pancreatic exocrine secretion. 
On the other hand, exogenous addition of ghrelin was investigated for its effect 
of digestive enzyme secretion on the isolated pancreatic acinar cells. In this regard, a 
wide range of concentration of ghrelin from to 10'^  M did not exert any effect 
on the a-amylase secretion after a 30-minute incubation (Fig. 3-18). 
These observations indicates that although ghrelin receptor was found to be 
present on pancreatic acinar cells in this study, ghrelin did not have direct effect 
mediated by its receptors of isolated acinar cells on pancreatic exocrine secretion. 
Such observations could be justified by previous reports. For instance, calcitonin 
gene-related peptide and somatostatin receptors are present on pancreatic acinar 
cells but do not appear to mediate pancreatic secretion [Esteve et al 1983; Bunnett 
et al 1991]. In addition, CCK was believed originally to act directly on the acinar 
cells to stimulate pancreatic secretion, as CCK receptors are present in abundance on 
pancreatic acini [Solomon 1994]. Furthermore, dispersed rat acinar cells appear to 
be sensitive to CCK at concentrations as low as 1 pM [Owyang and Williams 1991]. 
However, recent studies showed strong evidence that CCK stimulated pancreatic 
secretion via cholinergic pathway rather than hormonal pathway [Adler et al 1991; 
Soudah et al 1992; Inoue et al 1984]. Therefore, although CCK receptors are 
present in abundance on acinar cells, they do not appear to play an exclusive role in 
mediating pancreatic secretion [Li and Owyang 1996]. 
It is well known that in addition to the direct effects of CCK or carbachol on 
the pancreatic acinar cells, a mechanism of potentiative interaction exists between 
cholinergic ACh and CCK. Moreover, interactions between secretin and ACh or 
secretin and CCK also result in potentiation. In order to investigate the potential 
potentiation of ghrelin, effects of ghrelin with co-incubation of CCK-8 and 
carbachol were demonstrated, respectively. Nevertheless, ghrelin displayed neither 
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additive nor potentiative effects with CCK-8 (Fig. 3-19) and carbachol (Fig. 3-20) in 
rat isolated acinar cells. 
As previously mentioned, the simulation of exocrine pancreatic secretion is 
complex, and apart from the gastrointestinal tract, the pancreas is the only other 
peripheral organ involved in both neural and hormonal mechanisms [Konturek et al 
2003a; Konturek et al. 2003b; Neibergall-Roth and Singer 2001]. The major role in 
the stimulation of enzyme-rich pancreatic secretion is played by autonomic nervous 
system (ANS), the enteric nervous system (ENS) and enterohormones, such as CCK 
and secretin. These systems are involved in pancreatic exocrine secretion, 
particularly by the excitation of sensory receptors of sensory nerves. This gives rise 
to short entero-pancreatic and long vago-vagal reflexes thus affecting pancreatic 
secretion (Fig. 1-10) [Konturek et al 2003a; Konturek et al 2003b; Neibergall-Roth 
and Singer 2001]. For example, CCK, as the most important stimulant of pancreatic 
enzyme secretion, binds to the CCK-receptor on the acinar cells through the 
endocrine pathway. It can also stimulate the pancreatic enzyme secretion via neural 
reflexes through the neurocrine pathway (Fig. 1-10) [Li and Owyang 1996]. In 
addition to digestive enzyme secretion, CCK has an important role in regulating 
gastrointestinal motility via short enteric reflexes and long vago-vagal reflexes, such 
as relaxation of proximal stomach combined with increased antral and pyloric 
contraction, increased duodenal motility, contraction of gall-bladder and relaxation 
of sphincter ofOddi [Konturek et al 2003a; Konturek et al 2003b]. 
In addition to CCK, ghrelin has also been found to have a role in 
gastrointestinal functions. ICV administration of ghrelin increased gastric acid 
output in a dose-dependent manner in anesthetized rats [Date et al. 2001]. Vagotomy 
and administration of atropine, which is a competitive antagonist of muscarinic 
cholinergic receptors, abolished the gastric acid secretion induced by ghrelin. 
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Furthermore, ICV administration of ghrelin also induced c-fos expression in the 
neurons of the nucleus of the dorsomotor nucleus of the vagus, which is a key site in 
the CNS for regulation of gastric acid secretion [Date et al. 2001]. These results 
suggested that ghrelin participated in the central regulation of gastric acid secretion 
by activating the vagus system. 
To investigate the possible effect and neural mechanism of ghrelin on 
pancreatic exocrine secretion, the action of ghrelin on pancreatic lobules containing 
intrapancreatic neurons was speculated in the present study. An intrapancreatic 
innervation exists in pancreatic lobules that enable a degree of independence of the 
pancreas when cut off from the CNS and the gut [Neibergall-Roth and Singer 2001]. 
The intrapancreatic nerves in pancreatic lobules were excited in a medium 
containing elevated depolarizing 75 mM potassium, which significantly increased 
a-amylase release. Ghrelin, at concentrations from to 10"^  M, dose-dependently 
decreased a-amylase release from pancreatic lobules exposed to potassium (Fig. 
3-21). It is believed that ghrelin exhibited an indirect inhibitory effect on pancreatic 
protein secretion via the intrapancreatic neurons in vitro. Similar results have been 
demonstrated by recent report [Zhang et al. 2001]. In that study, it was proposed that 
the actions of ghrelin on pancreatic secretion were directed at the level of 
intrapancreatic neurons. In an in vivo study, ghrelin abolished pancreatic exocrine 
secretion stimulated by 2-deoxy-D-glucose, a centrally acting vagal stimulant. 
However, only partially inhibited pancreatic secretion stimulated by CCK or 
bethanechol, which is a cholinergic agent related to ACh. On the other hand, 
vagotomy failed to reverse the inhibitory effects of ghrelin on CCK stimulation of 
pancreatic secretion in anesthetized rats. This study suggested that ghrelin was a 
potent inhibitor of pancreatic exocrine secretion in anesthetized rats which might 
affect intrapancreatic neurotransmission mechanism [Zhang et al. 2001]. In contrast, 
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a recent report has demonstrated that an ICV administration of ghrelin in conscious 
rats significantly increased pancreatic fluid and protein output in a dose-dependent 
manner [Sato et al. 2003]. Moreover, pretreatment with the ganglion blocker 
hexamethonium and with atropine completely abolished the stimulatory effect of 
central ghrelin. This study suggested that centrally administered ghrelin stimulated 
pancreatic secretion through the vagus nerves in conscious rats. The discrepancy of 
these observations could be due, in part, to the differences in the experimental 
conditions. Previous studies have reported that physiological control of pancreatic 
secretion may be different in anesthetized and conscious rats or in vivo, and in vitro 
experiments [O'Rourke et al. 1991]. Therefore, the action and mechanism of ghrelin 
on exocrine pancreas is complicated and controversial which needs further 
investigations. 
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4.4 Effect of ghrelin on intracellular calcium mobilization in AR42J cells 
The existence of mRNA and protein expression of ghrelin and GHSR in 
exocrine pancreas has been discussed in section 4.1. It is suggested that ghrelin may 
have a role in regulating exocrine pancreas via an autocrine and/or paracrine fashion. 
This speculation was further substantiated by the study on the stimulatory effects of 
CCK-8, ghrelin and GHRP-6 on intracellular calcium signalling in AR42J cells. 
Among these agonists, CCK-8 was the most potent with the half-maximal response 
observed at ICT" M (Fig. 3-25). This concentration in picomolar concentration 
suggests that CCK-8 probably acts in an endocrine manner. In contrast, ghrelin was 
four orders of magnitude less potent than CCK-8 with the half-maximal response 
observed at 5 x 10'^  M (Fig. 3-25). This value is higher than the physiological 
concentration of ghrelin (10"'® M) [Jeffery et al. 2003], suggesting that ghrelin may 
act on the pancreas probably via an autocrine and/or paracrine fashion. On the other 
hand, the GHRP-6-induced increase was dose-dependent with the 
half-maximal response observed at 10'^  M (Fig. 3-25). The amplitude of the 
GHRP-6 response was much smaller as well. Thus the endogenous ligand ghrelin is 
a more potent GHS than the synthetic GHRP-6. 
The present study describes some novel findings on the potential pathway of 
[Ca2+]i signalling for ghrelin in exocrine pancreatic AR42J cells. Consistent with 
previous reports [Simeone et al 1995], CCK-8 dose dependently increased [Ca^^Ji in 
AR42J cells (Fig. 3-22). This was presumably attributed to mobilization of [Ca^^ji 
[Sjodin et al 1990]. The transient [Ca^^i elevation evoked by CCK-8 was different 
from the responses observed for both ghrelin and GHRP-6. The dose-dependent 
action of ghrelin on mobilization in AR42J cells is a biphasic one with an 
initial transient phase and a slow decline phase (Fig. 3-23). Similar to our results, in 
porcine pituitary somatotropes, perfusion with 1 i^M ghrelin for 2 minutes produced 
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a prompt transient increase in followed by a slow decline, to pre-stimulation 
levels of fluorescence [Cassoni et al 2001; Malagon et al 2003]. The plateau 
response was present even 30 minutes after the application of ghrelin. In transfected 
HEK-293 cells highly expressing the ghrelin receptor, binding of ghrelin to the 
receptor also induced a biphasic increase of [Ca^ ]^； characterized by a transient rise, 
followed by a gradual decrease [Masuda et al. 2000]. The synthetic peptide GHRP-6 
is an agonist for the ghrelin receptor that increased corresponding to the 
biphasic profile in somatotropes described in some reports [Bresson-Bepoldin and 
Dufy-Barbe 1994; Gracia-Navarro et al 2002; Herrington and Hille 1994]. In the 
present study, GHRP-6 produced a less potent response with a similar 
dynamics to ghrelin. GHRP-6 (10"^  M) induced a biphasic elevation with a 
rapid increase lasting for several seconds and then slow declined to basal level 
lasting for several minutes in AR42J cells (Fig. 3-24). Taken together, ghrelin and 
GHRP-6 could trigger a similar [Ca ]i biphasic response in pancreatic exocrine 
AR42J cells, presumably via two distinct calcium sources. 
To further study whether the stimulatory effect of ghrelin on in AR42J 
cells is mediated through the ghrelin receptor, a specific competitive antagonist, 
(D-Lys^)-GHRP-6, was employed [Cheng et al 1989]. In this regard, the 
stimulatory effect of ghrelin was significantly decreased in the presence of the 
receptor antagonist, supporting that ghrelin acts through its receptor in AR42J cells 
(Fig. 3-26). However, (D-Lys^)-GHRP-6 failed to completely suppress the increase 
[Ca2+]i evoked by ghrelin. This observation could be due, in part, to a lower affinity 
of (D-Lys^)-GHRP-6 for the ghrelin receptor as compared to that of ghrelin 
[Traebert et al. 2002]. In addition, the possibility of different subtypes of ghrelin 
receptor cannot be ruled out [Chen 2000; Dieguez and Casanueva 2000]. 
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A number of potential second messengers that are involved in the action of 
ghrelin have been previously reported. In transfected HEK-293 cells, binding of 
ghrelin to its receptor leads to the mobilization of Ca^^ from intracellular 
IPs-sensitive stores, thus activating Ca^ "^  influx through L-type voltage sensitive 
calcium channels. This suggests that the spike phase reflects IPs-mediated 
intracellular mobilization of Ca^^ while the plateau phase reflects the influx of 
extracellular Ca^ "^  across the plasma membrane [Camina et al 2003a; Camina et al 
2003b; Glavaski-Joksimovic et al 2003; Howard et al. 1996]. In contrast, some 
reports have shown that the response of porcine somatotropes to ghrelin relies on the 
activation of three distinct systems of second messengers, including the AC/PKA, 
PLC/PKC, and extracellular calcium systems [Kohno et al. 2003; Malagon et al 
2003]. In arcuate nucleus neuron, ghrelin-induced increase depends mainly 
on the Ca2+ influx through N-type calcium channels and the AC/PKA pathway, but 
not the L-type calcium channels nor the PLC/PKC pathway. 
In this study, depletion of extracellular Ca^^ greatly reduced the 
response of ghrelin and completely abolished the slow decline phase of the 
stimulatory effect of ghrelin on AR42J cells, i.e. the spike phase persisted but was 
markedly inhibited (Fig. 3-27). These results indicate that the initial transient 
increase depends on both intracellular store release and extracellular Ca^^ influx 
whereas the slow decline phase was extracellular Ca^ "^  dependent. These data further 
suggest that ghrelin could mobilize Ca^^ from intracellular stores and immediately 
trigger Ca〗. influx, both mechanisms contributing to the stimulatory effect of 
ghrelin. Interestingly, 2-APB [Maruyama et al 1997] and xestospongin C [Gafni et 
al. 1997], the IP3 receptor blockers, abolished the transient phase of the ghrelin 
effect on [Ca2+]i，indicating the involvement of the PLC/PKC pathway in ghrelin 
action on AR42J cells (Fig. 3-28). It is therefore envisaged that in AR42J cells 
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expressing ghrelin receptor, ghrelin acts on phosphatidylinositol-4,5-bisphosphate 
generating IP3 and diacylglycerol (DAG). IP3 triggers the release of Ca^ "^  from 
IP3-intracellular sensitive stores whereas DAG is responsible for the activation of 
PKC. The IPs-sensitive Ca^ "^  pool appears to be dynamically coupled to extracellular 
Ca2+. When the Ca2+ levels are reduced, the aperture of capacitative calcium 
channels at the plasma membrane triggers a Ca^^  influx that is consistent with the 
effect of ghrelin on transfected HEK-293 cells [Camina et al 2003a; Camina et al 
2003b; Glavaski-Joksimovic et al 2003]. Both blockers failed to completely 
suppress the increase evoked by ghrelin and the small extent of [Ca^ ""]； 
2+ 
increase was probably attributed to extracellular Ca . This could be explained by 
the incomplete blockade of IP3 receptors by 2-APB and xestospongin C. 
In conclusion, this study gives evidence for the potential Ca^ "" signalling 
pathway in pancreatic exocrine cells. This information is biologically significant 
particularly in view of the fact that CCK-8, being an important regulator of 
pancreatic enzyme secretion, triggers Ca^^  signalling in these cells in a different 
fashion to ghrelin. To date, limited information on the ftmction of ghrelin in the 
exocrine pancreas was available. In the present study, the indirect inhibitory effect 
of ghrelin on pancreatic protein secretion via the intrapancreatic innervation in vitro 
has been demonstrated and mentioned in section 4.3. It appears that ghrelin exerts 
no direct effect on acinar cells in regulating pancreatic enzyme secretion. Therefore, 
we conclude that the direct action of ghrelin on AR42J cells triggering Ca^ "" 
signalling cannot be accountable for regulating pancreatic secretion, but other 
functions of ghrelin in exocrine pancreas. For instance, administration of ghrelin 
could attenuate pancreatic damage in cemlein-induced pancreatitis [Dembinski et al. 
2003]. Moreover, ghrelin promotes pancreatic adenocarcinoma cellular proliferation 
and invasiveness [Duxbury et al. 2003]. Apart from these studies, ghrelin has been 
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shown to stimulate zona glomerulosa cell proliferation in the adrenal cortex, thus 
implicating a potential role of ghrelin on the growth effect on pancreatic exocrine 
cells [Andreis et al 2003]. In addition, in view of the complexity involved and the 
inconsistency of information in the reported literature, the function and signalling 




There are few and certainly no conclusive descriptions of the ghrelin system 
and its possible functions in pancreatic exocrine acinar cells. The present study gives 
a first insight into the ghrelin system of the exocrine pancreas. As a first step of the 
present study, it was hypothesized the presence of a ghrelin system in pancreatic 
exocrine acinar cells. In this regard, the mRNA and protein of ghrelin and GHSR 
were found to express in acinar cells and AR42J cells. These data indicate the 
existence of a ghrelin system in the exocrine pancreas that might be operated in an 
autocrine and/or paracrine pathway in regulating acinar functions. 
These findings prompt us to further study the physiological and 
pathophysiolgical regulations of such a ghrelin system and its potential role on 
pancreatic enzyme secretion. In this regard, the expression of GHSR was 
upregulated by omeprazole-induced gastric acid inhibition while downregulated by 
acute pancreatitis; however, the expression of ghrelin was not affected by these 
treatments. On the other hand, starvation did not cause any changes on the 
expression of both ghrelin and GHSR in pancreatic acinar cells. It is believed that 
the differential changes in GHSR could play a role in physiology and 
pathophysiology of the pancreas. Nevertheless, the significance of its regulation 
remains undefined and merits further investigations. 
As there are only limited and controversial observations of ghrelin action on 
pancreatic enzyme secretion, the in vitro studies of ghrelin in dispersed acinar cells 
and in pancreatic lobules were studied. Our data suggest that ghrelin did not display 
any direct effect on dispersed acinar cells while an indirect and dose-dependent 
inhibitory effect on pancreatic lobules was observed. It is believed that ghrelin might 
exhibit an indirect inhibitory effect on pancreatic exocrine secretion via the 
mediation of intrapancreatic nervous pathway. 
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In the present study, another significant finding is the demonstration of 
functional expression of GHSR in AR42J cells. The supraphysiological 
concentration of ghrelin (5 x 10"^  M) increased leads to the support to the 
evidence that ghrelin may act on the pancreas, probably via an autocrine and/or 
paracrine fashion. In addition, both ghrelin and GHRP-6 triggered a biphasic [Ca^ "^ ]； 
elevation with a rapid increase and then declined to a sustained response in AR42J 
cells mediated specifically through ghrelin receptor. It is also demonstrated that the 
initial transient increase depends on both intracellular store release and extracellular 
Ca2+ influx whereas the sustained plateau phase was extracellular Ca^^ dependent. 
Moreover, our results suggest the involvement of the PLC/PKC pathway in ghrelin 
action on AR42J cells. 
In summary, the present study has established a function correlate between 
ghrelin system and exocrine pancreas. These findings open up new directions for 
future research that would give a fuller understanding on the physiological 
significance of ghrelin system in the exocrine pancreas. 
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4.6 Future works 
The potential functions and regulatory mechanisms of the ghrelin system in the 
exocrine pancreas are still undefined and controversial. The present study gives the 
evidence of the indirect inhibitory effect of ghrelin via intrapancreatic innervation in 
in vitro pancreatic lobules. Apart from that, the involvement of cholinergic 
vago-vagal pathway and entero-pancreatic pathway need to be investigated in in vivo 
studies. Different parameters of the experimental conditions should be studied, such 
as, in conscious or anesthetized rats, at physiological or supraphysiological levels of 
ghrelin as well as in ICV administration or intravenous infusion of ghrelin. These 
parameters probably lead to differential observations on the action and mechanism 
of ghrelin on pancreatic exocrine secretion. 
On the other hand, the present study indicates the significance of PI-PLC 
pathway in the action of ghrelin on AR42J cells, but it could not eliminate the 
involvement of AC-PKA pathway in ghrelin action. Therefore, to explore a better 
view of signal transduction mechanisms, with special attention to Ca^^  signalling 
with the AC-PKA pathway should be further investigated. This could be achieved by 
pretreatment of the AR42J cells with PKA inhibitor, H89 as well as the addition of 
AC activator, forskolin or 12-0-tetradecanoylphorbol-13-acetate (TPA). Moreover, 
to determine the type of plasma membrane Ca 2+ channels responsible for the 
extracellular Ca^ ' influx, specific channel blockers should also be used. For instance, 
an N-type Ca channel blocker, co-concotoxin GVIA or L-type Ca channel blocker, 
nifedipine should be pretreated in AR42J cells before the excitation of ghrelin. 
Finally, the potential role of ghrelin on exocrine secretion appears to be 
controversal. As dicussed, ghrelin promotes pancreatic adenocarcinoma cellular 
proliferation. [Duxbury et al, 2003] and stimulates zona glomerulosa cell 
proliferation in the adrenal cortex [Andreis et al 2003], thus implicating a potential 
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role of ghrelin on the growth effect on pancreatic exocrine cells. Therefore, cell 
proliferation in both pancreatic exocrine acinar cells and tumor cell line AR42J 
could be performed to elaborate this action of ghrelin. 
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